RxNorm Semantic Concepts Index - 238
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "238".
RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
---|---|---|---|---|
RxCUI: 238003 | estradiol 0.05 MG/Day Weekly Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238003 | estradiol 0.05 MG/Day Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238003 | estradiol 0.05 MG/Day Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238003 | estradiol 0.05 MG/Day Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238004 | estradiol 0.1 MG/Day Weekly Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238004 | estradiol 0.1 MG/Day Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238004 | estradiol 0.1 MG/Day Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238004 | estradiol 0.1 MG/Day Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238006 | estrogens, esterified 0.625 MG / methylTESTOSTERone 1.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238006 | estrogens, esterified 0.625 MG / methylTESTOSTERone 1.25 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 238006 | estrogens, esterified 0.625 MG / methylTESTOSTERone 1.25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238006 | estrogens, esterified 0.625 MG / methylTESTOSTERone 1.25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 238006 | estrogens, esterified 0.625 MG / methylTESTOSTERone 1.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238006 | estrogens, esterified 0.625 MG / methylTESTOSTERone 1.25 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 238011 | Ergometrine 200 microgram/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238011 | Ergometrine 200 microgram/mL solution for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238011 | Ergometrine 200 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 238011 | Ergometrine 200 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 238013 | oxytocin 10 UNT/ML Injectable Solution | Designated preferred name (PT) | YES | |
RxCUI: 238013 | oxytocin 10 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238013 | oxytocin 10 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238013 | oxytocin 10 UNT/ML Injectable Solution | Full form of descriptor (FN) | YES | |
RxCUI: 238014 | carboprost tromethamine 250 MCG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238014 | carboprost tromethamine 250 MCG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238014 | carboprost tromethamine 250 MCG in 1 ML Injection | Designated preferred name (PT) | YES | |
RxCUI: 238014 | carboprost tromethamine 250 MCG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238014 | carboprost tromethamine 250 MCG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238014 | carboprost tromethamine 250 MCG in 1 ML Injection | Full form of descriptor (FN) | YES | |
RxCUI: 238015 | norethindrone 0.4 MG / ethinyl estradiol 0.035 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238015 | norethindrone 0.4 MG / ethinyl estradiol 0.035 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 238015 | norethindrone 0.4 MG / ethinyl estradiol 0.035 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238015 | norethindrone 0.4 MG / ethinyl estradiol 0.035 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238015 | norethindrone 0.4 MG / ethinyl estradiol 0.035 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 238019 | levonorgestrel 0.15 MG / ethinyl estradiol 0.03 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238019 | levonorgestrel 0.15 MG / ethinyl estradiol 0.03 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 238019 | levonorgestrel 0.15 MG / ethinyl estradiol 0.03 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238019 | levonorgestrel 0.15 MG / ethinyl estradiol 0.03 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238019 | levonorgestrel 0.15 MG / ethinyl estradiol 0.03 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 238020 | estradiol 10 MG / ethinyl estradiol 5 MG / levonorgestrel 6 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238021 | nonoxynol-9 2 % Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238021 | nonoxynol-9 2 % Vaginal Gel | Designated preferred name (PT) | YES | |
RxCUI: 238021 | nonoxynol-9 2 % Vaginal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238021 | nonoxynol-9 2 % Vaginal Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238021 | nonoxynol-9 2 % Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238021 | nonoxynol-9 2 % Vaginal Gel | Full form of descriptor (FN) | YES | |
RxCUI: 238023 | octoxynol-9 1 % Vaginal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238023 | octoxynol-9 1 % Vaginal Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 238023 | octoxynol-9 1 % Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380230 | insulin lispro-aabc 100 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2380231 | insulin lispro-aabc 100 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2380231 | insulin lispro-aabc 100 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2380232 | Lyumjev | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2380233 | insulin lispro-aabc 100 UNT/ML [Lyumjev] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2380234 | insulin lispro Injectable Solution [Lyumjev] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2380235 | Lyumjev Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2380236 | LYUMJEV 100 UNT/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2380236 | LYUMJEV 100 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2380236 | LYUMJEV 100 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380240 | insulin lispro Pen Injector [Lyumjev] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2380248 | insulin lispro-aabc 100 UNT in 3 ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380248 | insulin lispro-aabc 100 UNT in 3 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380248 | insulin lispro-aabc 100 UNT in 3 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380249 | insulin lispro Cartridge [Lyumjev] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2380250 | LYUMJEV 100 UNT/ML in 3 ML Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380250 | LYUMJEV 100 UNT/ML in 3 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380250 | LYUMJEV 100 UNT/ML in 3 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380250 | LYUMJEV 100 UNT/ML in 3 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380251 | insulin lispro-aabc 100 UNT/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380252 | insulin lispro-aabc 100 UNT/ML Cartridge [Lyumjev] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380252 | insulin lispro-aabc 100 UNT/ML Cartridge [Lyumjev] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380253 | insulin lispro-aabc 200 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2380254 | insulin lispro-aabc 200 UNT/ML in 3 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2380254 | insulin lispro-aabc 200 UNT/ML in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2380254 | insulin lispro-aabc 200 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380255 | insulin lispro-aabc 200 UNT/ML [Lyumjev] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2380256 | LYUMJEV 200 UNT/ML in 3 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2380256 | LYUMJEV 200 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380256 | LYUMJEV 200 UNT/ML in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2380256 | LYUMJEV 200 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380257 | insulin lispro-aabc 200 UNT/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380258 | insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380258 | insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380259 | insulin lispro-aabc 100 UNT/ML in 3 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2380259 | insulin lispro-aabc 100 UNT/ML in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2380259 | insulin lispro-aabc 100 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380260 | LYUMJEV 100 UNT/ML in 3 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2380260 | LYUMJEV 100 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380260 | LYUMJEV 100 UNT/ML in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2380260 | LYUMJEV 100 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380261 | insulin lispro-aabc 100 UNT/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380262 | insulin lispro-aabc 100 UNT/ML Pen Injector [Lyumjev] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380262 | insulin lispro-aabc 100 UNT/ML Pen Injector [Lyumjev] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380265 | insulin lispro-aabc 100 UNT/ML in 3 ML Pen Injector, 0.5 UNT Doses | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380265 | insulin lispro-aabc 100 UNT/ML in 3 ML Pen Injector, 0.5 UNT Doses | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380265 | insulin lispro-aabc 100 UNT/ML in 3 ML Pen Injector, 0.5 UNT Doses | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380266 | LYUMJEV 100 UNT/ML in 3 ML Pen Injector, 0.5 UNT Doses | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380266 | LYUMJEV 100 UNT/ML in 3 ML Pen Injector, 0.5 UNT Doses | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380266 | LYUMJEV 100 UNT/ML in 3 ML Pen Injector, 0.5 UNT Doses | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380267 | insulin lispro-aabc 100 UNT/ML in 3 ML Pen Injector with Sensor | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2380267 | insulin lispro-aabc 100 UNT/ML in 3 ML Pen Injector with Sensor | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380267 | insulin lispro-aabc 100 UNT/ML in 3 ML Pen Injector with Sensor | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2380268 | LYUMJEV Tempo 100 UNT/ML in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2380268 | LYUMJEV Tempo 100 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380268 | LYUMJEV Tempo 100 UNT/ML in 3 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2380268 | LYUMJEV Tempo 100 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238030 | Procaine 10 mg/mL solution for injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238030 | Procaine 10 mg/mL solution for injection | Designated preferred name (PT) | NO | |
RxCUI: 238030 | Procaine 10 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
RxCUI: 238031 | procaine 20 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380327 | benzalkonium chloride 0.2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380327 | benzalkonium chloride 0.2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380327 | benzalkonium chloride 0.2 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380339 | amphotericin B Topical Cream [Fungizone] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2380341 | Derman | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2380342 | undecylenic acid 0.02 MG/MG / zinc undecylenate 0.2 MG/MG [Derman] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2380343 | undecylenate Topical Powder [Derman] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2380344 | Derman Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2380346 | undecylenic acid 50 MG/ML / zinc undecylenate 180 MG/ML [Derman] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2380347 | undecylenate Topical Cream [Derman] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2380349 | Celadrin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2380350 | menthol 15 MG/ML [Celadrin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2380351 | menthol Topical Cream [Celadrin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2380352 | Celadrin Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2380354 | menthol 12.5 MG/ML [Celadrin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2380356 | Tact | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2380357 | diphenhydramine hydrochloride 20 MG/ML / levomenthol 10 MG/ML [Tact] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2380357 | diphenhydramine hydrochloride 20 MG/ML / levomenthol 10 MG/ML [Tact] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2380358 | diphenhydramine / levomenthol Topical Cream [Tact] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2380358 | diphenhydramine / levomenthol Topical Cream [Tact] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2380359 | Tact Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2380361 | diphenhydramine hydrochloride 0.02 MG/MG / levomenthol 0.01 MG/MG [Tact] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2380361 | diphenhydramine hydrochloride 0.02 MG/MG / levomenthol 0.01 MG/MG [Tact] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2380362 | diphenhydramine / levomenthol Topical Gel [Tact] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2380362 | diphenhydramine / levomenthol Topical Gel [Tact] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2380364 | urea 150 MG/ML [Rea-Lo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2380370 | poly-L-lysine (30000-70000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2380371 | gelatin type a porcine (160 bloom) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2380373 | fostemsavir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2380373 | fostemsavir | Designated preferred name (PT) | YES | |
RxCUI: 2380373 | fostemsavir | Full form of descriptor (FN) | YES | |
RxCUI: 2380373 | fostemsavir | Designated preferred name (PT) | YES | |
RxCUI: 2380373 | fostemsavir | Full form of descriptor (FN) | YES | |
RxCUI: 2380374 | Fostemsavir trometamol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380374 | Fostemsavir trometamol | Full form of descriptor (FN) | YES | |
RxCUI: 2380374 | Fostemsavir trometamol | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2380374 | Fostemsavir trometamol | Designated preferred name (PT) | YES | |
RxCUI: 2380375 | (2-(((2-(2-amino-3-hydroxy-2-(hydroxymethyl)propoxy)-1-hydroxypropyl)hydroxyphosphoryl)oxy)-1-hydroxypropyl)phosphonic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2380376 | (2-(((2-(2-amino-3-hydroxy-2-(hydroxymethyl)propoxy)-1-hydroxypropyl)hydroxyphosphoryl)oxy)-1-hydroxypropyl)phosphonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2380536 | fostemsavir Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2380536 | fostemsavir Oral Product | Designated preferred name (PT) | YES | |
RxCUI: 2380536 | fostemsavir Oral Product | Full form of descriptor (FN) | YES | |
RxCUI: 2380537 | fostemsavir Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2380538 | fostemsavir Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2380540 | Rukobia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2380542 | fostemsavir Extended Release Oral Tablet [Rukobia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2380543 | Rukobia Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2380544 | Rukobia Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2380548 | fostemsavir 600 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2380549 | fostemsavir 600 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380549 | fostemsavir 600 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2380549 | fostemsavir 600 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380549 | fostemsavir 600 MG 12HR Extended Release Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 2380549 | fostemsavir 600 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380549 | fostemsavir 600 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2380549 | fostemsavir 600 MG 12HR Extended Release Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 2380550 | fostemsavir 600 MG [Rukobia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2380551 | Rukobia 600 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380551 | Rukobia 600 MG 12HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2380551 | Rukobia 600 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380551 | Rukobia 600 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2380552 | fostemsavir 600 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380553 | fostemsavir 600 MG Extended Release Oral Tablet [Rukobia] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380554 | hydrogen peroxide 500 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2380555 | hydrogen peroxide 50 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380555 | hydrogen peroxide 50 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380555 | hydrogen peroxide 50 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380556 | bivalirudin trifluoroacetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2380557 | bivalirudin 5 MG/ML [Angiomax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2380558 | ANGIOMAX RTU 250 MG in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380558 | ANGIOMAX RTU 250 MG in 50 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2380558 | ANGIOMAX RTU 250 MG in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380558 | ANGIOMAX RTU 250 MG in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380558 | ANGIOMAX RTU 250 MG in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2380559 | bivalirudin 5 MG/ML Injection [Angiomax] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380559 | bivalirudin 5 MG/ML Injection [Angiomax] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380560 | metoclopramide 15 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2380561 | metoclopramide Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2380562 | metoclopramide Nasal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2380563 | metoclopramide Nasal Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2380564 | metoclopramide 15 MG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380564 | metoclopramide 15 MG/ACTUAT Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2380564 | metoclopramide 15 MG/ACTUAT Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2380565 | Gimoti | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2380566 | metoclopramide 15 MG/ACTUAT [Gimoti] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2380567 | metoclopramide Nasal Spray [Gimoti] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2380568 | Gimoti Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2380569 | Gimoti Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2380570 | Gimoti 15 MG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380570 | Gimoti 15 MG/ACTUAT Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2380570 | Gimoti 15 MG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380570 | Gimoti 15 MG/ACTUAT Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2380571 | Rosa multiflora whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2380572 | Pratia purpurascens extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2380574 | influenza A virus A/Victoria/2454/2019 (H1N1) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2380575 | influenza B virus B/Victoria/705/2018 antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2380576 | influenza virus vaccine 2020-2021 (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380576 | influenza virus vaccine 2020-2021 (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380576 | influenza virus vaccine 2020-2021 (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380577 | Fluzone Quadrivalent 2020-2021 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2380578 | influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluzone Quadrivalent 2020-2021] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2380579 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2020-2021] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2380580 | Fluzone Quadrivalent 2020-2021 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2380581 | Fluzone Quadrivalent 2020-2021 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380581 | Fluzone Quadrivalent 2020-2021 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380581 | Fluzone Quadrivalent 2020-2021 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380582 | influenza virus vaccine 2020-2021 (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) 0.25 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380582 | influenza virus vaccine 2020-2021 (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) 0.25 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380582 | influenza virus vaccine 2020-2021 (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) 0.25 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380583 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2020-2021] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2380584 | Fluzone Quadrivalent 2020-2021 vaccine 0.25 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380584 | Fluzone Quadrivalent 2020-2021 vaccine 0.25 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380584 | Fluzone Quadrivalent 2020-2021 vaccine 0.25 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380585 | influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020-2021] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380586 | influenza virus vaccine 2020-2021 (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) 0.5 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380586 | influenza virus vaccine 2020-2021 (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) 0.5 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380586 | influenza virus vaccine 2020-2021 (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) 0.5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380587 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Fluzone Quadrivalent 2020-2021] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2380588 | Fluzone Quadrivalent 2020-2021 vaccine 0.5 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380588 | Fluzone Quadrivalent 2020-2021 vaccine 0.5 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380588 | Fluzone Quadrivalent 2020-2021 vaccine 0.5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380589 | influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380590 | influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2020-2021] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380591 | Fluzone Quadrivalent 2020-2021 vaccine 0.5 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380591 | Fluzone Quadrivalent 2020-2021 vaccine 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380591 | Fluzone Quadrivalent 2020-2021 vaccine 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380592 | influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2380593 | influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2380594 | influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen / influenza A virus A/Victoria/2454/2019 (H1N1) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Victoria/705/2018 antigen | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 2380595 | influenza virus vaccine 2020-2021 (quadrivalent - Hong Kong/Victoria/Phuket/Victoria) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380595 | influenza virus vaccine 2020-2021 (quadrivalent - Hong Kong/Victoria/Phuket/Victoria) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380595 | influenza virus vaccine 2020-2021 (quadrivalent - Hong Kong/Victoria/Phuket/Victoria) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380596 | Afluria Quadrivalent 2020-2021 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2380597 | influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML [Afluria Quadrivalent 2020-2021] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2380598 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria Quadrivalent 2020-2021] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2380599 | Afluria Quadrivalent 2020-2021 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 23806 | Echarin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 23806 | Echarin | Designated preferred name (PT) | NO | |
RxCUI: 23806 | Echarin | Full form of descriptor (FN) | NO | |
RxCUI: 2380600 | afluria Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380600 | afluria Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380600 | afluria Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380601 | influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380602 | influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2020-2021] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380603 | influenza virus vaccine 2020-2021 (quadrivalent - Hong Kong/Victoria/Phuket/Victoria) 0.25 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380603 | influenza virus vaccine 2020-2021 (quadrivalent - Hong Kong/Victoria/Phuket/Victoria) 0.25 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380603 | influenza virus vaccine 2020-2021 (quadrivalent - Hong Kong/Victoria/Phuket/Victoria) 0.25 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380604 | afluria Quadrivalent 2020-2021 vaccine 0.25 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380604 | afluria Quadrivalent 2020-2021 vaccine 0.25 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380604 | afluria Quadrivalent 2020-2021 vaccine 0.25 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380605 | influenza virus vaccine 2020-2021 (quadrivalent - Hong Kong/Victoria/Phuket/Victoria) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380605 | influenza virus vaccine 2020-2021 (quadrivalent - Hong Kong/Victoria/Phuket/Victoria) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380605 | influenza virus vaccine 2020-2021 (quadrivalent - Hong Kong/Victoria/Phuket/Victoria) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380606 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2020-2021] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2380607 | afluria Quadrivalent 2020-2021 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380607 | afluria Quadrivalent 2020-2021 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380607 | afluria Quadrivalent 2020-2021 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380608 | octreotide Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2380609 | octreotide Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2380610 | octreotide Delayed Release Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2380611 | octreotide 20 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380611 | octreotide 20 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2380611 | octreotide 20 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2380612 | Mycapssa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2380613 | octreotide 20 MG [Mycapssa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2380614 | octreotide Delayed Release Oral Capsule [Mycapssa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2380615 | Mycapssa Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2380616 | Mycapssa Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2380617 | Mycapssa 20 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2380617 | Mycapssa 20 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380617 | Mycapssa 20 MG Delayed Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 23807 | Ecdysone 20-monooxygenase | Designated preferred name (PT) | NO | |
RxCUI: 23807 | Ecdysone 20-monooxygenase | Full form of descriptor (FN) | NO | |
RxCUI: 2380769 | chlorhexidine gluconate 1.27 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2380770 | chlorhexidine gluconate 0.127 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380770 | chlorhexidine gluconate 0.127 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380770 | chlorhexidine gluconate 0.127 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380771 | emapalumab-lzsg 100 MG in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2380771 | emapalumab-lzsg 100 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2380771 | emapalumab-lzsg 100 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380772 | Gamifant 100 MG in 20 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2380772 | Gamifant 100 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2380772 | Gamifant 100 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2380772 | Gamifant 100 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 23808 | Ecdysone oxidase | Designated preferred name (PT) | NO | |
RxCUI: 23808 | Ecdysone oxidase | Full form of descriptor (FN) | NO | |
RxCUI: 238082 | ketamine 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238082 | ketamine 10 MG/ML Injectable Solution | Designated preferred name (PT) | YES | |
RxCUI: 238082 | ketamine 10 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238082 | ketamine 10 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238082 | ketamine 10 MG/ML Injectable Solution | Full form of descriptor (FN) | YES | |
RxCUI: 238083 | ketamine 100 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238083 | ketamine 100 MG/ML Injectable Solution | Designated preferred name (PT) | YES | |
RxCUI: 238083 | ketamine 100 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238083 | ketamine 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238083 | ketamine 100 MG/ML Injectable Solution | Full form of descriptor (FN) | YES | |
RxCUI: 2380831 | isostearamidopropyl epoxypropyl dimonium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2380832 | terpinolene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2380833 | 2-methoxy-1-propanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2380834 | influenza A virus A/Delaware/39/2019 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2380835 | influenza A virus A/Hawaii/70/2019 (H1N1) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2380836 | influenza A virus A/Minnesota/41/2019 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2380837 | influenza A virus A/Nebraska/14/2019 (H1N1) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2380838 | influenza B virus B/Darwin/7/2019 antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2380839 | influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 238084 | ketamine 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238084 | ketamine 50 MG/ML Injectable Solution | Designated preferred name (PT) | YES | |
RxCUI: 238084 | ketamine 50 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238084 | ketamine 50 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238084 | ketamine 50 MG/ML Injectable Solution | Full form of descriptor (FN) | YES | |
RxCUI: 2380840 | influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2380841 | influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2380842 | influenza A virus A/Delaware/39/2019 (H3N2) antigen / influenza A virus A/Nebraska/14/2019 (H1N1) antigen / influenza B virus B/Darwin/7/2019 antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 2380843 | influenza virus vaccine 2020-2021 (quadrivalent - Delaware/Nebraska/Darwin/Singapore) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380843 | influenza virus vaccine 2020-2021 (quadrivalent - Delaware/Nebraska/Darwin/Singapore) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380843 | influenza virus vaccine 2020-2021 (quadrivalent - Delaware/Nebraska/Darwin/Singapore) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380844 | Flucelvax Quadrivalent 2020-2021 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2380845 | influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2020-2021] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2380846 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flucelvax Quadrivalent 2020-2021] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2380847 | Flucelvax Quadrivalent 2020-2021 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2380848 | FLUCELVAX Quadrivalent 2020-2021 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380848 | FLUCELVAX Quadrivalent 2020-2021 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380848 | FLUCELVAX Quadrivalent 2020-2021 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380849 | influenza virus vaccine 2020-2021 (quadrivalent - Delaware/Nebraska/Darwin/Singapore) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380849 | influenza virus vaccine 2020-2021 (quadrivalent - Delaware/Nebraska/Darwin/Singapore) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380849 | influenza virus vaccine 2020-2021 (quadrivalent - Delaware/Nebraska/Darwin/Singapore) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380850 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax Quadrivalent 2020-2021] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2380851 | FLUCELVAX Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380851 | FLUCELVAX Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380851 | FLUCELVAX Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380852 | influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380853 | influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2020-2021] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380854 | influenza A virus A/Hawaii/70/2019 (H1N1) antigen 0.09 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2380855 | influenza A virus A/Minnesota/41/2019 (H3N2) antigen 0.09 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2380856 | influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2380857 | influenza A virus A/Hawaii/70/2019 (H1N1) antigen / influenza A virus A/Minnesota/41/2019 (H3N2) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 2380858 | influenza virus vaccine 2020-2021 (quadrivalent generic for Flublok - Hawaii/Minnesota/Phuket/Washington) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380858 | influenza virus vaccine 2020-2021 (quadrivalent generic for Flublok - Hawaii/Minnesota/Phuket/Washington) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380858 | influenza virus vaccine 2020-2021 (quadrivalent generic for Flublok - Hawaii/Minnesota/Phuket/Washington) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380859 | Flublok Quadrivalent 2020-2021 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2380860 | influenza A virus A/Hawaii/70/2019 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Minnesota/41/2019 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML [Flublok Quadrivalent 2020-2021] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2380861 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flublok Quadrivalent 2020-2021] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2380862 | Flublok Quadrivalent 2020-2021 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2380863 | FLUBLOK QUADRIVALENT 2020-2021 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380863 | FLUBLOK QUADRIVALENT 2020-2021 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380863 | FLUBLOK QUADRIVALENT 2020-2021 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380864 | influenza A virus A/Hawaii/70/2019 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Minnesota/41/2019 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380865 | influenza A virus A/Hawaii/70/2019 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Minnesota/41/2019 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2020-2021] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2380866 | povidone-iodine 12.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2380867 | povidone-iodine 1.25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380867 | povidone-iodine 1.25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380867 | povidone-iodine 1.25 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380868 | povidone-iodine 17.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2380869 | povidone-iodine 1.75 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2380869 | povidone-iodine 1.75 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2380869 | povidone-iodine 1.75 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2380870 | dimyristyldimonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2380871 | dimyristyldimonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 238090 | PENTobarbital sodium 50 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238090 | PENTobarbital sodium 50 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238090 | PENTobarbital sodium 50 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 238093 | paraldehyde Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 238097 | chamomile flowers 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238100 | LORazepam 2 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238100 | LORazepam 2 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238100 | LORazepam 2 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 238101 | LORazepam 4 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238101 | LORazepam 4 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238101 | LORazepam 4 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 238101 | LORazepam 4 MG/ML Injectable Solution | Designated preferred name (PT) | YES | |
RxCUI: 238101 | LORazepam 4 MG/ML Injectable Solution | Full form of descriptor (FN) | YES | |
RxCUI: 238104 | perphenazine 5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238107 | deanol 250 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 238107 | deanol 250 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2381130 | chlorhexidine / miconazole Topical Spray [Malaseb] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2381131 | Malaseb 2 % / 2 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2381131 | Malaseb 2 % / 2 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2381132 | laurylpyridinium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2381133 | laurylpyridinium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2381134 | Phanera variegata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2381135 | fenfluramine 2.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2381136 | fenfluramine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2381137 | fenfluramine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2381138 | fenfluramine 2.2 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2381138 | fenfluramine 2.2 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2381138 | fenfluramine 2.2 MG/mL Oral Solution | Designated preferred name (PT) | YES | |
RxCUI: 2381138 | fenfluramine 2.2 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2381138 | fenfluramine 2.2 MG/mL Oral Solution | Full form of descriptor (FN) | YES | |
RxCUI: 2381139 | Fintepla | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2381140 | fenfluramine 2.2 MG/ML [Fintepla] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2381141 | fenfluramine Oral Solution [Fintepla] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2381142 | Fintepla Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2381143 | Fintepla Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2381144 | Fintepla 2.2 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2381144 | Fintepla 2.2 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2381144 | Fintepla 2.2 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2381144 | Fintepla 2.2 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2381145 | influenza virus vaccine 2020-2021 (Hong Kong/Victoria/Victoria) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2381145 | influenza virus vaccine 2020-2021 (Hong Kong/Victoria/Victoria) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2381145 | influenza virus vaccine 2020-2021 (Hong Kong/Victoria/Victoria) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2381146 | Fluad 2020-2021 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2381147 | influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML [Fluad 2020-2021] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2381148 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad 2020-2021] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2381149 | Fluad 2020-2021 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2381150 | FLUAD 2020-2021 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2381150 | FLUAD 2020-2021 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2381150 | FLUAD 2020-2021 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2381151 | influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2381152 | influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2020-2021] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 238118 | acetaminophen / aspirin / caffeine / codeine / salicylamide Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 23812 | Ecgonine | Designated preferred name (PT) | NO | |
RxCUI: 23812 | Ecgonine | Full form of descriptor (FN) | NO | |
RxCUI: 238129 | buprenorphine HCl 0.3 MG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238129 | buprenorphine HCl 0.3 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238129 | buprenorphine HCl 0.3 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238129 | buprenorphine HCl 0.3 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238133 | pentazocine 30 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238133 | pentazocine 30 MG/ML Injectable Solution | Designated preferred name (PT) | YES | |
RxCUI: 238133 | pentazocine 30 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238133 | pentazocine 30 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238133 | pentazocine 30 MG/ML Injectable Solution | Full form of descriptor (FN) | YES | |
RxCUI: 238134 | butalbital 50 MG / aspirin 325 MG / caffeine 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238134 | butalbital 50 MG / aspirin 325 MG / caffeine 40 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238134 | butalbital 50 MG / aspirin 325 MG / caffeine 40 MG Oral Capsule | Designated preferred name (PT) | YES | |
RxCUI: 238134 | butalbital 50 MG / aspirin 325 MG / caffeine 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238134 | butalbital 50 MG / aspirin 325 MG / caffeine 40 MG Oral Capsule | Full form of descriptor (FN) | YES | |
RxCUI: 238135 | butalbital 50 MG / aspirin 325 MG / caffeine 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238135 | butalbital 50 MG / aspirin 325 MG / caffeine 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238135 | butalbital 50 MG / aspirin 325 MG / caffeine 40 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 238135 | butalbital 50 MG / aspirin 325 MG / caffeine 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238135 | butalbital 50 MG / aspirin 325 MG / caffeine 40 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 238137 | acetaminophen / aspirin / caffeine / salicylamide Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 238142 | acetaminophen / aspirin / caffeine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 238144 | ASA 130 MG Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238144 | ASA 130 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238145 | ASA 195 MG Rectal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238145 | ASA 195 MG Rectal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238148 | acetaminophen / caffeine / salicylamide Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 238151 | mesalamine 4 GM per 60 mL Enema | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238151 | mesalamine 4 GM per 60 mL Enema | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238151 | mesalamine 4 GM per 60 mL Enema | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238151 | mesalamine 4 GM per 60 mL Enema | Designated preferred name (PT) | YES | |
RxCUI: 238151 | mesalamine 4 GM per 60 mL Enema | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238151 | mesalamine 4 GM per 60 mL Enema | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238151 | mesalamine 4 GM per 60 mL Enema | Full form of descriptor (FN) | YES | |
RxCUI: 238153 | butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238153 | butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Capsule | Designated preferred name (PT) | YES | |
RxCUI: 238153 | butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238153 | butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238153 | butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238153 | butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Capsule | Full form of descriptor (FN) | YES | |
RxCUI: 238154 | butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238154 | butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 238154 | butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238154 | butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238154 | butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238154 | butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 238155 | APAP 500 MG / Caffeine 32 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238155 | APAP 500 MG / Caffeine 32 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238159 | acetaminophen 500 MG in 5 mL Oral Solution | Designated preferred name (PT) | YES | |
RxCUI: 238159 | acetaminophen 500 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238159 | acetaminophen 500 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238159 | acetaminophen 500 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238159 | acetaminophen 500 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238159 | acetaminophen 500 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238159 | acetaminophen 500 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238159 | acetaminophen 500 MG in 5 mL Oral Solution | Full form of descriptor (FN) | YES | |
RxCUI: 238160 | acetaminophen 120 MG in 2.5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 238160 | acetaminophen 120 MG in 2.5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238160 | acetaminophen 120 MG in 2.5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2381635 | benzalkonium chloride 0.1 % / ethanol 75 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2381635 | benzalkonium chloride 0.1 % / ethanol 75 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2381635 | benzalkonium chloride 0.1 % / ethanol 75 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2381730 | ethanol / isopropyl alcohol Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2381731 | ethanol 70 % / isopropyl alcohol 0.5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2381731 | ethanol 70 % / isopropyl alcohol 0.5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2381731 | ethanol 70 % / isopropyl alcohol 0.5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2381732 | ethanol / isopropyl alcohol Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2381733 | ethanol / isopropyl alcohol Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2381734 | ethanol 70 % / isopropyl alcohol 0.5 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2381734 | ethanol 70 % / isopropyl alcohol 0.5 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2381734 | ethanol 70 % / isopropyl alcohol 0.5 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2381735 | ethanol 70 % / isopropyl alcohol 0.5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2381735 | ethanol 70 % / isopropyl alcohol 0.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2381735 | ethanol 70 % / isopropyl alcohol 0.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2381736 | ethanol 60 % / isopropyl alcohol 10 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2381736 | ethanol 60 % / isopropyl alcohol 10 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2381736 | ethanol 60 % / isopropyl alcohol 10 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2381737 | isopropyl alcohol 0.05 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2381738 | ethanol 65 % / isopropyl alcohol 5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2381738 | ethanol 65 % / isopropyl alcohol 5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2381738 | ethanol 65 % / isopropyl alcohol 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238174 | ipecac 0.15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238175 | methocarbamol 1000 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238175 | methocarbamol 1000 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238175 | methocarbamol 1000 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2381830 | isopropyl alcohol 0.12 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2381831 | benzalkonium / ethanol / isopropyl alcohol Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2381832 | benzalkonium / ethanol / isopropyl alcohol Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2381833 | benzalkonium / ethanol / isopropyl alcohol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 2381834 | benzalkonium chloride 0.2 % / ethanol 58 % / isopropyl alcohol 12 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2381834 | benzalkonium chloride 0.2 % / ethanol 58 % / isopropyl alcohol 12 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2381834 | benzalkonium chloride 0.2 % / ethanol 58 % / isopropyl alcohol 12 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2382 | chloroguanide | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2382 | chloroguanide | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2382 | chloroguanide | Full form of descriptor (FN) | YES | |
RxCUI: 2382 | chloroguanide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2382 | chloroguanide | Designated preferred name (PT) | YES | |
RxCUI: 2382 | chloroguanide | Full form of descriptor (FN) | YES | |
RxCUI: 2382 | chloroguanide | Designated preferred name (PT) | YES | |
RxCUI: 238212 | glycopyrrolate 0.2 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238212 | glycopyrrolate 0.2 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238212 | glycopyrrolate 0.2 MG/ML Injectable Solution | Designated preferred name (PT) | YES | |
RxCUI: 238212 | glycopyrrolate 0.2 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238212 | glycopyrrolate 0.2 MG/ML Injectable Solution | Full form of descriptor (FN) | YES | |
RxCUI: 238223 | methoxamine 2 % Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 238223 | methoxamine 2 % Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238223 | methoxamine 2 % Injectable Solution | Designated preferred name (PT) | NO | |
RxCUI: 238223 | methoxamine 2 % Injectable Solution | Full form of descriptor (FN) | NO | |
RxCUI: 238231 | phenylpropanolamine HCl 25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238231 | phenylpropanolamine HCl 25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238232 | phenylpropanolamine HCl 25 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238232 | phenylpropanolamine HCl 25 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238233 | mephentermine 15 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238234 | mephentermine 30 MG/ML Injectable Solution | Designated preferred name (PT) | NO | |
RxCUI: 238234 | mephentermine 30 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238234 | mephentermine 30 MG/ML Injectable Solution | Full form of descriptor (FN) | NO | |
RxCUI: 238240 | tolazoline 25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2382431 | caprylyl glyceryl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2382435 | Fluad Quadrivalent 2020-2021 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2382436 | influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML [Fluad Quadrivalent 2020-2021] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2382437 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad Quadrivalent 2020-2021] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2382438 | Fluad Quadrivalent 2020-2021 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2382439 | FLUAD Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2382439 | FLUAD Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2382439 | FLUAD Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2382440 | influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Fluad Quadrivalent 2020-2021] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2382593 | dioctyldimonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2382595 | hyaluronidase-zzxf | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2382596 | hyaluronidase-zzxf 2000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2382597 | pertuzumab-zzxf | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2382598 | pertuzumab-zzxf 80 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2382599 | trastuzumab-zzxf | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 238260 | caffeine 200 MG / phenylpropanolamine HCl 50 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238260 | caffeine 200 MG / phenylpropanolamine HCl 50 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2382600 | trastuzumab-zzxf 40 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2382601 | hyaluronidase / pertuzumab / trastuzumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2382602 | hyaluronidase / pertuzumab / trastuzumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2382603 | hyaluronidase / pertuzumab / trastuzumab | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 2382604 | pertuzumab-trastuzumab-hyaluronidase-zzxf 1,200 MG / 600 MG / 30,000 UNT in 15 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2382604 | pertuzumab-trastuzumab-hyaluronidase-zzxf 1,200 MG / 600 MG / 30,000 UNT in 15 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2382604 | pertuzumab-trastuzumab-hyaluronidase-zzxf 1,200 MG / 600 MG / 30,000 UNT in 15 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2382605 | Phesgo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2382606 | hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 80 MG/ML / trastuzumab-zzxf 40 MG/ML [Phesgo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2382607 | hyaluronidase / pertuzumab / trastuzumab Injection [Phesgo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2382608 | Phesgo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2382609 | PHESGO 1,200 MG / 600 MG / 30,000 UNT in 15 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2382609 | PHESGO 1,200 MG / 600 MG / 30,000 UNT in 15 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2382609 | PHESGO 1,200 MG / 600 MG / 30,000 UNT in 15 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238261 | phenylpropanolamine HCl 15 MG / vitamin C 75 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238261 | phenylpropanolamine HCl 15 MG / vitamin C 75 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 238261 | phenylpropanolamine HCl 15 MG / vitamin C 75 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238261 | phenylpropanolamine HCl 15 MG / vitamin C 75 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238261 | phenylpropanolamine HCl 15 MG / vitamin C 75 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2382610 | hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 80 MG/ML / trastuzumab-zzxf 40 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2382611 | hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 80 MG/ML / trastuzumab-zzxf 40 MG/ML Injection [Phesgo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2382613 | pertuzumab-zzxf 60 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2382614 | trastuzumab-zzxf 60 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 238270 | Hyaluronidase 1500 unit powder for solution for injection ampule | British preferred term (PTGB) | NO | |
RxCUI: 238270 | Hyaluronidase 1500 unit powder for solution for injection ampule | Designated preferred name (PT) | NO | |
RxCUI: 238270 | Hyaluronidase 1500 unit powder for solution for injection ampule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238270 | Hyaluronidase 1500 unit powder for solution for injection ampule | Full form of descriptor (FN) | NO | |
RxCUI: 238271 | hyaluronidase, bovine 150 UNT in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238271 | hyaluronidase, bovine 150 UNT in 1 ML Injection | Designated preferred name (PT) | YES | |
RxCUI: 238271 | hyaluronidase, bovine 150 UNT in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238271 | hyaluronidase, bovine 150 UNT in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238271 | hyaluronidase, bovine 150 UNT in 1 ML Injection | Full form of descriptor (FN) | YES | |
RxCUI: 238272 | povidone-iodine 1 % Oral Rinse | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 238272 | povidone-iodine 1 % Oral Rinse | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238272 | povidone-iodine 1 % Oral Rinse | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2382810 | Chlorella emersonii extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2382989 | selinexor 60 MG Twice Weekly (120 MG total weekly) Dose Carton Pack, 20 MG oral Tablet 24 Count Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2382989 | selinexor 60 MG Twice Weekly (120 MG total weekly) Dose Carton Pack, 20 MG oral Tablet 24 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2382989 | selinexor 60 MG Twice Weekly (120 MG total weekly) Dose Carton Pack, 20 MG oral Tablet 24 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2382990 | XPOVIO 60 MG Twice Weekly (120 MG total weekly) Dose Carton Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2382990 | XPOVIO 60 MG Twice Weekly (120 MG total weekly) Dose Carton Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2382990 | XPOVIO 60 MG Twice Weekly (120 MG total weekly) Dose Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2382991 | XPOVIO 40 MG Twice Weekly (80 MG total weekly) Dose Carton Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2382991 | XPOVIO 40 MG Twice Weekly (80 MG total weekly) Dose Carton Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2382991 | XPOVIO 40 MG Twice Weekly (80 MG total weekly) Dose Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2382992 | selinexor 40 MG Weekly Dose Carton Pack, 20 MG oral Tablet 8 Count Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2382992 | selinexor 40 MG Weekly Dose Carton Pack, 20 MG oral Tablet 8 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2382992 | selinexor 40 MG Weekly Dose Carton Pack, 20 MG oral Tablet 8 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2382993 | XPOVIO 40 MG Weekly Dose Carton Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2382993 | XPOVIO 40 MG Weekly Dose Carton Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2382993 | XPOVIO 40 MG Weekly Dose Carton Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2383007 | petrolatum 0.865 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2383008 | petrolatum 86.5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2383008 | petrolatum 86.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2383008 | petrolatum 86.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2383028 | levorphanol tartrate 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2383030 | levorphanol tartrate 2 MG/ML [L-Dromoran] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2383032 | levorphanol tartrate 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2383034 | levorphanol tartrate 2 MG [L-Dromoran] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2383303 | camellia reticulata seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2383305 | pertuzumab-trastuzumab-hyaluronidase-zzxf 600 MG / 600 MG / 20,000 UNT in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2383305 | pertuzumab-trastuzumab-hyaluronidase-zzxf 600 MG / 600 MG / 20,000 UNT in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2383305 | pertuzumab-trastuzumab-hyaluronidase-zzxf 600 MG / 600 MG / 20,000 UNT in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2383306 | hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 60 MG/ML / trastuzumab-zzxf 60 MG/ML [Phesgo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2383307 | Phesgo 600 MG / 600 MG / 20,000 UNT in 10 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2383307 | Phesgo 600 MG / 600 MG / 20,000 UNT in 10 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2383307 | Phesgo 600 MG / 600 MG / 20,000 UNT in 10 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2383308 | hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 60 MG/ML / trastuzumab-zzxf 60 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2383309 | hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 60 MG/ML / trastuzumab-zzxf 60 MG/ML Injection [Phesgo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2383310 | benzalkonium chloride 0.1 % / ethanol 70 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2383310 | benzalkonium chloride 0.1 % / ethanol 70 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2383310 | benzalkonium chloride 0.1 % / ethanol 70 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2383333 | tolnaftate Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2383334 | tolnaftate Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2383335 | tolnaftate 1 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2383335 | tolnaftate 1 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2383335 | tolnaftate 1 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2383336 | salicylic acid 0.2 % / zinc pyrithione 0.3 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2383336 | salicylic acid 0.2 % / zinc pyrithione 0.3 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2383336 | salicylic acid 0.2 % / zinc pyrithione 0.3 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2383337 | carbon tetrachloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2383338 | citronitrile | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2383339 | dioxolane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2383340 | glycereth-25 PCA isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2383341 | glyceryl dipalmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2383342 | triethanolamine cocoyl glutaminate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2383350 | benzethonium Topical Solution [New-Skin Liquid Bandage] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2383351 | New-Skin Liquid Bandage 0.2 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2383351 | New-Skin Liquid Bandage 0.2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2383351 | New-Skin Liquid Bandage 0.2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2383351 | New-Skin Liquid Bandage 0.2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2383532 | Safrole | Designated preferred name (PT) | YES | |
RxCUI: 2383532 | Safrole | Full form of descriptor (FN) | YES | |
RxCUI: 2383532 | Safrole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2383532 | Safrole | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2383533 | allyl heptanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2383534 | dioxane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2383536 | triethylene amine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2383538 | 2,4,5-T-isopropyl | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2383539 | 2-tert-butylcyclohexyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2383540 | hexacyanoferrate II | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2383540 | hexacyanoferrate II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2383541 | sodium ferrocyanide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2383542 | influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.0857 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2383543 | influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.0857 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2383544 | influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2383545 | influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2383546 | influenza virus vaccine 2020-2021 high-dose (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) 0.7 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2383546 | influenza virus vaccine 2020-2021 high-dose (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) 0.7 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2383546 | influenza virus vaccine 2020-2021 high-dose (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) 0.7 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2383547 | influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.0857 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML [Fluzone Quadrivalent 2020-2021] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2383548 | Fluzone Quadrivalent 2020-2021 high-dose vaccine 0.7 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2383548 | Fluzone Quadrivalent 2020-2021 high-dose vaccine 0.7 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2383548 | Fluzone Quadrivalent 2020-2021 high-dose vaccine 0.7 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2383549 | influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.0857 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2383550 | influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.0857 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020-2021] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2383551 | triheptanoin 1000 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2383552 | triheptanoin Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2383553 | triheptanoin Oral Product | Full form of descriptor (FN) | YES | |
RxCUI: 2383553 | triheptanoin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2383553 | triheptanoin Oral Product | Designated preferred name (PT) | YES | |
RxCUI: 2383554 | triheptanoin Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2383555 | triheptanoin 8.3 kcal/mL (100 % ) Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2383555 | triheptanoin 8.3 kcal/mL (100 % ) Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2383555 | triheptanoin 8.3 kcal/mL (100 % ) Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2383555 | triheptanoin 8.3 kcal/mL (100 % ) Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2383556 | Dojolvi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2383557 | triheptanoin 1000 MG/ML [Dojolvi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2383558 | triheptanoin Oral Solution [Dojolvi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2383559 | Dojolvi Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2383560 | Dojolvi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2383561 | DOJOLVI 8.3 kcal/mL (100 % ) Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2383561 | DOJOLVI 8.3 kcal/mL (100 % ) Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2383561 | DOJOLVI 8.3 kcal/mL (100 % ) Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2383561 | DOJOLVI 8.3 kcal/mL (100 % ) Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 238379 | silicones 30 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238379 | silicones 30 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 238379 | silicones 30 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2383930 | 2-sec-butyl cyclohexanone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2383931 | allyl cyclohexanepropionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2383932 | citrus juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2383933 | ebanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2383934 | hydrogenated poly(C6-20 olefin; 100 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2383935 | isopropylphenylbutanal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2383936 | PEG-7 oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2383937 | propylene glycol 2-behenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2383938 | sakuranin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2383939 | styrene/isoprene/styrene block copolymer (styrene/isoprene 15/85) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2383940 | tetrahydrolinalyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2383941 | remimazolam | Full form of descriptor (FN) | YES | |
RxCUI: 2383941 | remimazolam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2383941 | remimazolam | Designated preferred name (PT) | YES | |
RxCUI: 2383941 | remimazolam | Full form of descriptor (FN) | YES | |
RxCUI: 2383941 | remimazolam | Designated preferred name (PT) | YES | |
RxCUI: 2383942 | remimazolam besylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2383942 | remimazolam besylate | Designated preferred name (PT) | YES | |
RxCUI: 2383942 | remimazolam besylate | Full form of descriptor (FN) | YES | |
RxCUI: 2383943 | remimazolam 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2383944 | remimazolam Injectable Product | Full form of descriptor (FN) | YES | |
RxCUI: 2383944 | remimazolam Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2383944 | remimazolam Injectable Product | Designated preferred name (PT) | YES | |
RxCUI: 2383945 | remimazolam Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2383946 | remimazolam 20 MG Injection | Full form of descriptor (FN) | YES | |
RxCUI: 2383946 | remimazolam 20 MG Injection | Designated preferred name (PT) | YES | |
RxCUI: 2383946 | remimazolam 20 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2383946 | remimazolam 20 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2383946 | remimazolam 20 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2383947 | Byfavo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2383948 | remimazolam 20 MG [Byfavo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2383949 | remimazolam Injection [Byfavo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2383950 | Byfavo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2383951 | Byfavo 20 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2383951 | Byfavo 20 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2383951 | Byfavo 20 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2383952 | capsaicin 0.025 % / menthol 4 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2383952 | capsaicin 0.025 % / menthol 4 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2383952 | capsaicin 0.025 % / menthol 4 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2383955 | Bacillus coagulans 800000000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2383956 | Bacillus coagulans Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2383957 | Bacillus coagulans 800,000,000 UNT Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2383957 | Bacillus coagulans 800,000,000 UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2383957 | Bacillus coagulans 800,000,000 UNT Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2384030 | mecobalamin 5 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2384030 | mecobalamin 5 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2384030 | mecobalamin 5 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238405 | zinc oxide 25 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238405 | zinc oxide 25 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238405 | zinc oxide 25 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238405 | zinc oxide 25 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2384130 | isopropyl alcohol Topical Lotion | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2384131 | isopropyl alcohol 70 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2384131 | isopropyl alcohol 70 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2384131 | isopropyl alcohol 70 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2384132 | hydrogen peroxide 40 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2384133 | ethanol / hydrogen peroxide Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 2384134 | ethanol / hydrogen peroxide Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2384135 | ethanol / hydrogen peroxide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 2384136 | ethanol 70 % / hydrogen peroxide 4 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2384136 | ethanol 70 % / hydrogen peroxide 4 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2384136 | ethanol 70 % / hydrogen peroxide 4 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2384137 | ethanol / isopropyl alcohol Topical Foam | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2384138 | ethanol 62 % / isopropyl alcohol 5 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2384138 | ethanol 62 % / isopropyl alcohol 5 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2384138 | ethanol 62 % / isopropyl alcohol 5 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238427 | ZnSO4 0.36 MG/MG Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238427 | ZnSO4 0.36 MG/MG Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2384439 | Lavandula latifolia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2384440 | .alpha.-amylcinnamaldehyde dimethyl acetal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2384441 | 8-(N-indolyl)-2,6-dimethyl-7-octen-2-ol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2384442 | methyl 2-furoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2384443 | methyl 2-nonynoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2384444 | polyglyceryl-10 pentaoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2384445 | antimony tartrate ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2384447 | benzalkonium chloride 0.00015 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2384448 | benzalkonium chloride 0.015 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2384448 | benzalkonium chloride 0.015 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2384448 | benzalkonium chloride 0.015 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2384449 | cedazuridine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2384449 | cedazuridine | Designated preferred name (PT) | YES | |
RxCUI: 2384449 | cedazuridine | Full form of descriptor (FN) | YES | |
RxCUI: 2384450 | benzalkonium chloride 0.23 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2384450 | benzalkonium chloride 0.23 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2384450 | benzalkonium chloride 0.23 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2384451 | cedazuridine 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2384452 | decitabine 35 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2384453 | cedazuridine / decitabine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2384453 | cedazuridine / decitabine Oral Product | Designated preferred name (PT) | YES | |
RxCUI: 2384453 | cedazuridine / decitabine Oral Product | Full form of descriptor (FN) | YES | |
RxCUI: 2384454 | cedazuridine / decitabine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2384455 | cedazuridine / decitabine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2384456 | cedazuridine / decitabine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 2384456 | cedazuridine / decitabine | Designated preferred name (PT) | YES | |
RxCUI: 2384456 | cedazuridine / decitabine | Full form of descriptor (FN) | YES | |
RxCUI: 2384457 | cedazuridine 100 MG / decitabine 35 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2384457 | cedazuridine 100 MG / decitabine 35 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2384457 | cedazuridine 100 MG / decitabine 35 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 2384457 | cedazuridine 100 MG / decitabine 35 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 2384458 | cedazuridine 100 MG / decitabine 35 MG (5) Oral Tablet Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2384458 | cedazuridine 100 MG / decitabine 35 MG (5) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2384458 | cedazuridine 100 MG / decitabine 35 MG (5) Oral Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2384459 | Inqovi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2384460 | cedazuridine 100 MG / decitabine 35 MG [Inqovi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2384461 | cedazuridine / decitabine Oral Tablet [Inqovi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2384462 | Inqovi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2384463 | Inqovi Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2384464 | INQOVI 35 MG / 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2384464 | INQOVI 35 MG / 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2384464 | INQOVI 35 MG / 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2384465 | INQOVI 5 Tablet Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2384465 | INQOVI 5 Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2384465 | INQOVI 5 Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238460 | salicylic acid 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238460 | salicylic acid 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238460 | salicylic acid 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238464 | salicylic acid Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 238465 | salicylic acid 10 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238465 | salicylic acid 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238465 | salicylic acid 10 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238466 | salicylic acid 150 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238470 | sodium hydroxide 10 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238470 | sodium hydroxide 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238470 | sodium hydroxide 10 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2384782 | polyglyceryl-2 palmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2384783 | N-(3-aminopropyl)-N-dodecyl-1,3-propanediamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2384784 | ethanol 77 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2384784 | ethanol 77 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2384784 | ethanol 77 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2385105 | Viola mandshurica flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2385106 | Artemisia argyi whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2385107 | Litsea glutinosa bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2385109 | styrene/isoprene/styrene block copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2385117 | diclofenac epolamine 1.3 % Once-Daily Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2385117 | diclofenac epolamine 1.3 % Once-Daily Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2385117 | diclofenac epolamine 1.3 % Once-Daily Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2385118 | diclofenac epolamine 0.013 MG/MG [Licart] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2385119 | Licart Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2385121 | Licart | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2385122 | diclofenac Medicated Patch [Licart] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 23852 | efloxate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2385330 | dimethyl benzyl carbinyl butyrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2385331 | allyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2385338 | methylal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2385339 | 1H-Benzotriazole | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2385339 | 1H-Benzotriazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2385339 | 1H-Benzotriazole | Designated preferred name (PT) | NO | |
RxCUI: 2385339 | 1H-Benzotriazole | Full form of descriptor (FN) | NO | |
RxCUI: 2385339 | 1H-Benzotriazole | Designated preferred name (PT) | NO | |
RxCUI: 2385339 | 1H-Benzotriazole | Full form of descriptor (FN) | NO | |
RxCUI: 2385340 | Pinene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2385340 | Pinene | Designated preferred name (PT) | YES | |
RxCUI: 2385340 | Pinene | Full form of descriptor (FN) | YES | |
RxCUI: 2385340 | Pinene | Designated preferred name (PT) | YES | |
RxCUI: 2385340 | Pinene | Full form of descriptor (FN) | YES | |
RxCUI: 2385341 | 1,3-bis((1-methylethyl)amino)propan-2-ol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2385342 | citric acid 0.01 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2385343 | lactic acid 0.018 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2385344 | potassium bitartrate 0.004 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2385345 | citric acid / lactate / potassium bitartrate Vaginal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2385346 | citric acid / lactate / potassium bitartrate Vaginal Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2385347 | citric acid / lactate / potassium bitartrate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 2385348 | lactic acid 1.8 % / citric acid 1 % / potassium bitartrate 0.4 % Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2385348 | lactic acid 1.8 % / citric acid 1 % / potassium bitartrate 0.4 % Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2385348 | lactic acid 1.8 % / citric acid 1 % / potassium bitartrate 0.4 % Vaginal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2385348 | lactic acid 1.8 % / citric acid 1 % / potassium bitartrate 0.4 % Vaginal Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2385348 | lactic acid 1.8 % / citric acid 1 % / potassium bitartrate 0.4 % Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2385349 | Phexxi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2385350 | citric acid 0.01 MG/MG / lactic acid 0.018 MG/MG / potassium bitartrate 0.004 MG/MG [Phexxi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2385351 | citric acid / lactate / potassium bitartrate Vaginal Gel [Phexxi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2385352 | Phexxi Vaginal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2385353 | PHEXXI 1.8 % / 1 % / 0.4 % Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2385353 | PHEXXI 1.8 % / 1 % / 0.4 % Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2385353 | PHEXXI 1.8 % / 1 % / 0.4 % Vaginal Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2385353 | PHEXXI 1.8 % / 1 % / 0.4 % Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2385353 | PHEXXI 1.8 % / 1 % / 0.4 % Vaginal Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238542 | methyl salicylate 25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238542 | methyl salicylate 25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238542 | methyl salicylate 25 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238543 | methyl salicylate Topical Oil | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 238561 | camphor Topical Oil | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 238580 | salicylic acid 2 % / lactic acid 0.5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238580 | salicylic acid 2 % / lactic acid 0.5 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238580 | salicylic acid 2 % / lactic acid 0.5 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 238581 | selenium sulfide 1 % / menthol 0.5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238581 | selenium sulfide 1 % / menthol 0.5 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238581 | selenium sulfide 1 % / menthol 0.5 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238584 | sulfur 2 MG/ML Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2385885 | 2-butoxyethanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2385886 | p-menthane-3,8-diol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2385887 | propylene glycol ethyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2385888 | 2-(phosphonooxy)- 2-propenoic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2385889 | 2-(phosphonooxy)- 2-propenoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 238600 | selenium sulfide 2.5 % Topical Suspension | Full form of descriptor (FN) | YES | |
RxCUI: 238600 | selenium sulfide 2.5 % Topical Suspension | Full form of descriptor (FN) | YES | |
RxCUI: 238600 | selenium sulfide 2.5 % Topical Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238600 | selenium sulfide 2.5 % Topical Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238600 | selenium sulfide 2.5 % Topical Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238600 | selenium sulfide 2.5 % Topical Suspension | Designated preferred name (PT) | YES | |
RxCUI: 238600 | selenium sulfide 2.5 % Topical Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238600 | selenium sulfide 2.5 % Topical Suspension | Designated preferred name (PT) | YES | |
RxCUI: 2386023 | benzalkonium chloride 0.2 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2386023 | benzalkonium chloride 0.2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386023 | benzalkonium chloride 0.2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2386025 | calamine 150 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2386026 | calamine 15 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386026 | calamine 15 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2386026 | calamine 15 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2386028 | 2-acetoxy-1, 8-cineole, (+)-endo- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2386029 | Gymnadenia conopsea whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2386035 | budesonide / formoterol / glycopyrronium Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2386036 | budesonide / formoterol / glycopyrronium Metered Dose Inhaler | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 238605 | allantoin 0.2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238605 | allantoin 0.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238605 | allantoin 0.2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2386053 | benzalkonium Cl 0.08 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2386053 | benzalkonium Cl 0.08 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2386053 | benzalkonium Cl 0.08 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386056 | isopropyl alcohol 74 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2386056 | isopropyl alcohol 74 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386056 | isopropyl alcohol 74 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238609 | chlorophyllin copper complex 14 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238621 | Bar Soap | Dose Form (DF) | NO | |
RxCUI: 2386212 | ethanol 0.82 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2386213 | ethanol 82 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2386213 | ethanol 82 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386213 | ethanol 82 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2386215 | decyltetradeceth-30 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2386216 | arginine cocoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2386217 | PEG-30 glyceryl cocoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2386218 | fluralaner 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2386219 | fluralaner 100 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386219 | fluralaner 100 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2386220 | fluralaner 100 MG [Bravecto] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2386221 | Bravecto 1-Month 100 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2386221 | Bravecto 1-Month 100 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386221 | Bravecto 1-Month 100 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2386222 | fluralaner 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2386223 | fluralaner 200 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386223 | fluralaner 200 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2386224 | fluralaner 200 MG [Bravecto] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2386225 | Bravecto 1-Month 200 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386225 | Bravecto 1-Month 200 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2386225 | Bravecto 1-Month 200 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2386226 | fluralaner 400 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2386227 | fluralaner 400 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386227 | fluralaner 400 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2386228 | fluralaner 400 MG [Bravecto] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2386229 | Bravecto 1-Month 400 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386229 | Bravecto 1-Month 400 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2386229 | Bravecto 1-Month 400 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2386230 | fluralaner 45 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2386231 | fluralaner 45 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386231 | fluralaner 45 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2386232 | fluralaner 45 MG [Bravecto] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2386233 | Bravecto 1-Month 45 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386233 | Bravecto 1-Month 45 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2386233 | Bravecto 1-Month 45 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2386234 | fluralaner 560 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2386235 | fluralaner 560 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386235 | fluralaner 560 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2386236 | fluralaner 560 MG [Bravecto] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2386237 | Bravecto 1-Month 560 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386237 | Bravecto 1-Month 560 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2386237 | Bravecto 1-Month 560 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2386238 | sodium hyaluronate 0.004 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2386239 | hyaluronate Ophthalmic Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2386240 | sodium hyaluronate 0.4 % Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2386240 | sodium hyaluronate 0.4 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386240 | sodium hyaluronate 0.4 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2386241 | disodium pamoate monohydrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2386333 | Centella asiatica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2386334 | HC blue no. 2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2386335 | HC yellow no. 2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2386336 | PEG-PPG-125-30 copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 238635 | urea 22 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238635 | urea 22 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 238635 | urea 22 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238636 | urea 40 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238636 | urea 40 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 238636 | urea 40 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2386438 | ethanol 0.93 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2386439 | ethanol 93 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2386439 | ethanol 93 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386439 | ethanol 93 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2386440 | benzalkonium chloride 0.13 % / ethanol 75 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386440 | benzalkonium chloride 0.13 % / ethanol 75 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2386440 | benzalkonium chloride 0.13 % / ethanol 75 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2386441 | benzalkonium chloride 0.14 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386441 | benzalkonium chloride 0.14 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2386441 | benzalkonium chloride 0.14 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238645 | dextran 1 150 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238657 | hemin 313 MG Injection | British preferred term (PTGB) | YES | |
RxCUI: 238657 | hemin 313 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238657 | hemin 313 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238657 | hemin 313 MG Injection | Designated preferred name (PT) | YES | |
RxCUI: 238657 | hemin 313 MG Injection | Full form of descriptor (FN) | YES | |
RxCUI: 238674 | lecithin 1140 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238675 | lecithin 1260 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238676 | lecithin Oral Granules | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 238677 | lecithin 1200 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 238677 | lecithin 1200 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2386842 | Euonymus europaeus seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2386843 | gamma-methacryloxypropyltrimethoxysilane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2386844 | benzalkonium chloride 0.05 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2386844 | benzalkonium chloride 0.05 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2386844 | benzalkonium chloride 0.05 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2386858 | cyclophosphamide 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2386858 | cyclophosphamide 200 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2386859 | cycloPHOSphamide 200 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2386859 | cycloPHOSphamide 200 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2386859 | cycloPHOSphamide 200 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2386863 | coagulation factor VIIa (recombinant)-jncw | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2386864 | coagulation factor VIIa (recombinant)-jncw 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2386865 | coagulation factor VIIa (recombinant)-jncw 5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2386865 | coagulation factor VIIa (recombinant)-jncw 5 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2386865 | coagulation factor VIIa (recombinant)-jncw 5 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2386866 | Sevenfact | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2386867 | coagulation factor VIIa (recombinant)-jncw 5 MG [Sevenfact] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2386868 | factor VIIa Injection [Sevenfact] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2386869 | Sevenfact Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 238687 | inositol Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2386870 | SevenFACT 5 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2386870 | SevenFACT 5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2386870 | SevenFACT 5 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2386871 | coagulation factor VIIa (recombinant)-jncw 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2386872 | coagulation factor VIIa (recombinant)-jncw 1 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2386872 | coagulation factor VIIa (recombinant)-jncw 1 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2386872 | coagulation factor VIIa (recombinant)-jncw 1 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2386873 | coagulation factor VIIa (recombinant)-jncw 1 MG [Sevenfact] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2386874 | SevenFACT 1 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2386874 | SevenFACT 1 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2386874 | SevenFACT 1 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238688 | inositol 325 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238691 | choline 600 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2387076 | palmitoyl tetrapeptide-10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2387077 | Smallanthus sonchifolius whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2387078 | vancomycin 1.25 GM in 250 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2387078 | vancomycin 1.25 GM in 250 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2387078 | vancomycin 1.25 GM in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387078 | vancomycin 1.25 GM in 250 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387079 | vancomycin 1.75 GM in 350 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2387079 | vancomycin 1.75 GM in 350 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2387079 | vancomycin 1.75 GM in 350 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387079 | vancomycin 1.75 GM in 350 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387083 | benzalkonium chloride 0.14 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2387083 | benzalkonium chloride 0.14 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2387083 | benzalkonium chloride 0.14 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238719 | aminocaproic acid 250 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238719 | aminocaproic acid 250 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238720 | tranexamic acid 1000 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238720 | tranexamic acid 1000 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238720 | tranexamic acid 1000 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387202 | benzalkonium chloride 0.1 % / ethanol 80 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2387202 | benzalkonium chloride 0.1 % / ethanol 80 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2387202 | benzalkonium chloride 0.1 % / ethanol 80 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2387204 | benzalkonium chloride 0.135 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2387204 | benzalkonium chloride 0.135 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2387204 | benzalkonium chloride 0.135 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238721 | SK 50000 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238721 | SK 50000 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2387211 | tafasitamab | Full form of descriptor (FN) | YES | |
RxCUI: 2387211 | tafasitamab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2387211 | tafasitamab | Designated preferred name (PT) | YES | |
RxCUI: 2387211 | tafasitamab | Full form of descriptor (FN) | YES | |
RxCUI: 2387211 | tafasitamab | Designated preferred name (PT) | YES | |
RxCUI: 2387277 | brexucabtagene autoleucel | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2387277 | brexucabtagene autoleucel | Designated preferred name (PT) | YES | |
RxCUI: 2387277 | brexucabtagene autoleucel | Full form of descriptor (FN) | YES | |
RxCUI: 2387277 | brexucabtagene autoleucel | Designated preferred name (PT) | YES | |
RxCUI: 2387277 | brexucabtagene autoleucel | Full form of descriptor (FN) | YES | |
RxCUI: 2387302 | Gamma hydroxybutyrate | Designated preferred name (PT) | YES | |
RxCUI: 2387302 | Gamma hydroxybutyrate | Full form of descriptor (FN) | YES | |
RxCUI: 2387302 | Gamma hydroxybutyrate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387302 | Gamma hydroxybutyrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2387307 | calcium oxybate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2387307 | calcium oxybate | Designated preferred name (PT) | YES | |
RxCUI: 2387307 | calcium oxybate | Full form of descriptor (FN) | YES | |
RxCUI: 2387308 | magnesium oxybate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2387308 | magnesium oxybate | Designated preferred name (PT) | YES | |
RxCUI: 2387308 | magnesium oxybate | Full form of descriptor (FN) | YES | |
RxCUI: 2387309 | potassium oxybate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2387309 | potassium oxybate | Designated preferred name (PT) | YES | |
RxCUI: 2387309 | potassium oxybate | Full form of descriptor (FN) | YES | |
RxCUI: 2387321 | budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2387322 | budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT Metered Dose Inhaler [Breztri] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2387323 | budesonide / formoterol / glycopyrronium Metered Dose Inhaler [Breztri] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2387324 | Breztri Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2387325 | Breztri | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2387326 | budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT 28 ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2387326 | budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT 28 ACTUAT Metered Dose Inhaler | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2387326 | budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT 28 ACTUAT Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387327 | budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT [Breztri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2387328 | BREZTRI 160/4.8/9 MCG/INHAL Metered Dose Inhaler, 28 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2387328 | BREZTRI 160/4.8/9 MCG/INHAL Metered Dose Inhaler, 28 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387328 | BREZTRI 160/4.8/9 MCG/INHAL Metered Dose Inhaler, 28 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2387329 | budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT 120 ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2387329 | budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT 120 ACTUAT Metered Dose Inhaler | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2387329 | budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.009 MG/ACTUAT 120 ACTUAT Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387330 | budesonide / formoterol / glycopyrronium | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 2387331 | BREZTRI 160/4.8/9 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2387331 | BREZTRI 160/4.8/9 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387331 | BREZTRI 160/4.8/9 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2387334 | tafasitamab-cxix | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2387335 | tafasitamab-cxix 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2387336 | tafasitamab Injectable Product | Full form of descriptor (FN) | YES | |
RxCUI: 2387336 | tafasitamab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2387336 | tafasitamab Injectable Product | Designated preferred name (PT) | YES | |
RxCUI: 2387337 | tafasitamab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2387338 | tafasitamab-cxix 200 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2387338 | tafasitamab-cxix 200 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2387339 | Monjuvi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2387340 | tafasitamab-cxix 200 MG [Monjuvi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2387341 | tafasitamab Injection [Monjuvi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2387342 | Monjuvi Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2387343 | MONJUVI 200 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2387343 | MONJUVI 200 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387343 | MONJUVI 200 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2387344 | brexucabtagene autoleucel 2940000 CELLS/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2387345 | brexucabtagene autoleucel Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2387345 | brexucabtagene autoleucel Injectable Product | Designated preferred name (PT) | YES | |
RxCUI: 2387345 | brexucabtagene autoleucel Injectable Product | Full form of descriptor (FN) | YES | |
RxCUI: 2387346 | brexucabtagene autoleucel Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2387347 | brexucabtagene autoleucel 200,000,000 CELLS in 68 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2387347 | brexucabtagene autoleucel 200,000,000 CELLS in 68 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2387347 | brexucabtagene autoleucel 200,000,000 CELLS in 68 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387348 | Tecartus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2387349 | brexucabtagene autoleucel 2940000 CELLS/ML [Tecartus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2387350 | brexucabtagene autoleucel Injection [Tecartus] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2387351 | Tecartus Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2387352 | Tecartus 200,000,000 CELLS in 68 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2387352 | Tecartus 200,000,000 CELLS in 68 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387352 | Tecartus 200,000,000 CELLS in 68 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2387352 | Tecartus 200,000,000 CELLS in 68 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387353 | brexucabtagene autoleucel 2940000 CELLS/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2387354 | brexucabtagene autoleucel 2940000 CELLS/ML Injection [Tecartus] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2387354 | brexucabtagene autoleucel 2940000 CELLS/ML Injection [Tecartus] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2387355 | dexAMETHasone 1.5 MG Tablet 7 Day 25 Count Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 2387355 | dexAMETHasone 1.5 MG Tablet 7 Day 25 Count Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2387355 | dexAMETHasone 1.5 MG Tablet 7 Day 25 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2387355 | dexAMETHasone 1.5 MG Tablet 7 Day 25 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387355 | dexAMETHasone 1.5 MG Tablet 7 Day 25 Count Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2387356 | ZCORT 1.5 MG Tablet 7 Day 25 Count Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 2387356 | ZCORT 1.5 MG Tablet 7 Day 25 Count Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 2387356 | ZCORT 1.5 MG Tablet 7 Day 25 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2387356 | ZCORT 1.5 MG Tablet 7 Day 25 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387531 | ibuprofen 125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2387532 | acetaminophen 250 MG / ibuprofen 125 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2387532 | acetaminophen 250 MG / ibuprofen 125 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2387532 | acetaminophen 250 MG / ibuprofen 125 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387533 | colloidal oatmeal 5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2387533 | colloidal oatmeal 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2387533 | colloidal oatmeal 5 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2387534 | ethanol 0.84 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2387535 | ethanol 84 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2387535 | ethanol 84 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2387535 | ethanol 84 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2387538 | Holodiscus discolor whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2387539 | Prunus persica fruiting top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 238754 | hydrocortisone 2.5 % Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238754 | hydrocortisone 2.5 % Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238754 | hydrocortisone 2.5 % Injectable Suspension | Designated preferred name (PT) | NO | |
RxCUI: 238754 | hydrocortisone 2.5 % Injectable Suspension | Full form of descriptor (FN) | NO | |
RxCUI: 2387540 | PEG-90 glyceryl isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2387542 | N,N-dimethyllauramide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2387543 | PEG/PPG-18/12 dimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2387544 | 2-bromo-2-methylpropane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2387545 | sodium chloride 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2387545 | sodium chloride 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2387545 | sodium chloride 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2387548 | ethanol 0.785 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2387549 | ethanol 78.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2387549 | ethanol 78.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2387549 | ethanol 78.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238755 | hydrocortisone sodium succinate 100 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238755 | hydrocortisone sodium succinate 100 MG Injection | Designated preferred name (PT) | YES | |
RxCUI: 238755 | hydrocortisone sodium succinate 100 MG Injection | Designated preferred name (PT) | YES | |
RxCUI: 238755 | hydrocortisone sodium succinate 100 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238755 | hydrocortisone sodium succinate 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238755 | hydrocortisone sodium succinate 100 MG Injection | Full form of descriptor (FN) | YES | |
RxCUI: 238755 | hydrocortisone sodium succinate 100 MG Injection | Full form of descriptor (FN) | YES | |
RxCUI: 2387550 | isopropyl alcohol Topical Foam | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2387551 | isopropyl alcohol 75 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2387551 | isopropyl alcohol 75 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2387551 | isopropyl alcohol 75 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2387830 | blackback flounder flesh extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387830 | blackback flounder flesh extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2387831 | glyceryl dioleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2387832 | PPG-4 myristyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2387833 | belantamab mafodotin-blmf | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 2387834 | belantamab mafodotin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2387834 | belantamab mafodotin | Designated preferred name (PT) | YES | |
RxCUI: 2387834 | belantamab mafodotin | Full form of descriptor (FN) | YES | |
RxCUI: 2387834 | belantamab mafodotin | Designated preferred name (PT) | YES | |
RxCUI: 2387834 | belantamab mafodotin | Full form of descriptor (FN) | YES | |
RxCUI: 2387835 | belantamab mafodotin-blmf 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2387836 | belantamab mafodotin Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2387836 | belantamab mafodotin Injectable Product | Designated preferred name (PT) | YES | |
RxCUI: 2387836 | belantamab mafodotin Injectable Product | Full form of descriptor (FN) | YES | |
RxCUI: 2387837 | belantamab mafodotin Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2387838 | belantamab mafodotin-blmf 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2387838 | belantamab mafodotin-blmf 100 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2387839 | Blenrep | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 238784 | dibucaine 1 % Rectal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238784 | dibucaine 1 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238784 | dibucaine 1 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387840 | belantamab mafodotin-blmf 100 MG [Blenrep] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2387841 | belantamab mafodotin Injection [Blenrep] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2387842 | Blenrep Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2387843 | BLENREP 100 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2387843 | BLENREP 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2387843 | BLENREP 100 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2387844 | belantamab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2388 | Chlorophyll | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2388 | Chlorophyll | Designated preferred name (PT) | YES | |
RxCUI: 2388 | Chlorophyll | Full form of descriptor (FN) | YES | |
RxCUI: 238803 | povidone-iodine 120 MG/ML Douche | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2388132 | sweet pea seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2388132 | sweet pea seed extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2388133 | fructone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2388133 | fructone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2388134 | citronellyl nitrile, (+/-) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2388136 | influenza A virus A/Hawaii/66/2019 (H1N1) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2388138 | benzalkonium chloride 0.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2388139 | benzalkonium / menthol Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 2388140 | benzalkonium chloride 0.04 % / menthol 0.1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2388140 | benzalkonium chloride 0.04 % / menthol 0.1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388140 | benzalkonium chloride 0.04 % / menthol 0.1 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2388149 | influenza A virus A/Hawaii/66/2019 (H1N1) antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2388150 | influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2388151 | influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2388173 | Twirla | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2388174 | ethanol 66 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2388174 | ethanol 66 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2388174 | ethanol 66 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238826 | hexylresorcinol Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2388333 | Prunus x yedoensis flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2388334 | Tylosema esculentum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2388335 | isopropyl alcohol 0.71 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2388336 | isopropyl alcohol 71 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2388336 | isopropyl alcohol 71 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2388336 | isopropyl alcohol 71 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388338 | Erdosteine only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388338 | Erdosteine only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388339 | Fluorodopa (18-F) only product | Designated preferred name (PT) | NO | |
RxCUI: 2388339 | Fluorodopa (18-F) only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388340 | Fluorodopa (18-F) only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388340 | Fluorodopa (18-F) only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388341 | Tularemia vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388341 | Tularemia vaccine | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 2388341 | Tularemia vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388341 | Tularemia vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388342 | Givosiran only product | Designated preferred name (PT) | NO | |
RxCUI: 2388342 | Givosiran only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388343 | Givosiran only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388343 | Givosiran only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388344 | Golodirsen only product | Designated preferred name (PT) | NO | |
RxCUI: 2388344 | Golodirsen only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388345 | Golodirsen only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388345 | Golodirsen only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388346 | Inactivated rabies vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388346 | Inactivated rabies vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388346 | Inactivated rabies vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388347 | Haemophilus influenzae type b and hepatitis B vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388347 | Haemophilus influenzae type b and hepatitis B vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388347 | Haemophilus influenzae type b and hepatitis B vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388348 | Haemophilus influenzae type b and meningitis C vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388348 | Haemophilus influenzae type b and meningitis C vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388348 | Haemophilus influenzae type b and meningitis C vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388349 | Haemophilus influenzae type b vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388349 | Haemophilus influenzae type b vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388349 | Haemophilus influenzae type b vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388350 | Haemophilus influenzae type b capsular polysaccharide conjugated vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388350 | Haemophilus influenzae type b capsular polysaccharide conjugated vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388350 | Haemophilus influenzae type b capsular polysaccharide conjugated vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388352 | Hepatitis A and typhoid vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388352 | Hepatitis A and typhoid vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388352 | Hepatitis A and typhoid vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388353 | Vaccine product containing only Vaccinia virus antigen (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2388353 | Vaccine product containing only Vaccinia virus antigen (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2388354 | Cholera vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388354 | Cholera vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388354 | Cholera vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388355 | Cholera vaccine in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388355 | Cholera vaccine in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388355 | Cholera vaccine in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388356 | Product containing only voxelotor (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2388356 | Product containing only voxelotor (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2388357 | Product containing only voxelotor in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2388357 | Product containing only voxelotor in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2388358 | Diphtheria toxoid and whole cell pertussis and tetanus toxoid pediatric vaccine | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 2388358 | Diphtheria toxoid and whole cell pertussis and tetanus toxoid pediatric vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388358 | Diphtheria toxoid and whole cell pertussis and tetanus toxoid pediatric vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388358 | Diphtheria toxoid and whole cell pertussis and tetanus toxoid pediatric vaccine | British preferred term (PTGB) | NO | |
RxCUI: 2388358 | Diphtheria toxoid and whole cell pertussis and tetanus toxoid pediatric vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388359 | Diphtheria toxoid and Haemophilus influenzae type b conjugate and whole cell pertussis and tetanus toxoid pediatric vaccine | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 2388359 | Diphtheria toxoid and Haemophilus influenzae type b conjugate and whole cell pertussis and tetanus toxoid pediatric vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388359 | Diphtheria toxoid and Haemophilus influenzae type b conjugate and whole cell pertussis and tetanus toxoid pediatric vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388359 | Diphtheria toxoid and Haemophilus influenzae type b conjugate and whole cell pertussis and tetanus toxoid pediatric vaccine | British preferred term (PTGB) | NO | |
RxCUI: 2388359 | Diphtheria toxoid and Haemophilus influenzae type b conjugate and whole cell pertussis and tetanus toxoid pediatric vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388360 | Yellow fever vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388360 | Yellow fever vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388360 | Yellow fever vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388361 | Plague vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388361 | Plague vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388361 | Plague vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388362 | Hepatitis A adult vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388362 | Hepatitis A adult vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388362 | Hepatitis A adult vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388363 | Hepatitis A pediatric vaccine | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 2388363 | Hepatitis A pediatric vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388363 | Hepatitis A pediatric vaccine | British preferred term (PTGB) | NO | |
RxCUI: 2388363 | Hepatitis A pediatric vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388363 | Hepatitis A pediatric vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388364 | Hepatitis A vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388364 | Hepatitis A vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388364 | Hepatitis A vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388365 | Hepatitis B surface antigen vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388365 | Hepatitis B surface antigen vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388365 | Hepatitis B surface antigen vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388366 | Hepatitis B vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388366 | Hepatitis B vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388366 | Hepatitis B vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388367 | Measles and mumps and rubella and varicella virus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388367 | Measles and mumps and rubella and varicella virus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388367 | Measles and mumps and rubella and varicella virus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388368 | Varicella-zoster vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388368 | Varicella-zoster vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388368 | Varicella-zoster vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388368 | Varicella-zoster vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388369 | Human papillomavirus 16 and 18 vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388369 | Human papillomavirus 16 and 18 vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388369 | Human papillomavirus 16 and 18 vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388370 | Human papillomavirus 6, 11, 16 and 18 vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388370 | Human papillomavirus 6, 11, 16 and 18 vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388370 | Human papillomavirus 6, 11, 16 and 18 vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388372 | Human papillomavirus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388372 | Human papillomavirus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388372 | Human papillomavirus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388373 | Human poliovirus antigen only vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2388373 | Human poliovirus antigen only vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2388374 | Product containing only zanubrutinib (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2388374 | Product containing only zanubrutinib (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2388375 | Product containing only zanubrutinib in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2388375 | Product containing only zanubrutinib in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2388376 | Inactivated hepatitis A and hepatitis B surface antigen vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388376 | Inactivated hepatitis A and hepatitis B surface antigen vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388376 | Inactivated hepatitis A and hepatitis B surface antigen vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388377 | Inactivated hepatitis A vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388377 | Inactivated hepatitis A vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388377 | Inactivated hepatitis A vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388378 | Inactivated polio vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388378 | Inactivated polio vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388378 | Inactivated polio vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388379 | Inactivated Japanese encephalitis virus adsorbed vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388379 | Inactivated Japanese encephalitis virus adsorbed vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388379 | Inactivated Japanese encephalitis virus adsorbed vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388380 | Inactivated Japanese encephalitis virus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388380 | Inactivated Japanese encephalitis virus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388380 | Inactivated Japanese encephalitis virus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388381 | Inactivated rabies virus vaccine grown in brain tissue | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388381 | Inactivated rabies virus vaccine grown in brain tissue | Designated preferred name (PT) | NO | |
RxCUI: 2388381 | Inactivated rabies virus vaccine grown in brain tissue | Full form of descriptor (FN) | NO | |
RxCUI: 2388382 | Inactivated rabies vaccine grown in cellular line | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388382 | Inactivated rabies vaccine grown in cellular line | Designated preferred name (PT) | NO | |
RxCUI: 2388382 | Inactivated rabies vaccine grown in cellular line | Full form of descriptor (FN) | NO | |
RxCUI: 2388383 | Inactivated cholera vaccine in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388383 | Inactivated cholera vaccine in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388383 | Inactivated cholera vaccine in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388384 | Influenza H1N1 vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388384 | Influenza H1N1 vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388384 | Influenza H1N1 vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388385 | Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage antigens only vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2388385 | Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage antigens only vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2388386 | Influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria lineage antigens only vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2388386 | Influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria lineage antigens only vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2388387 | Influenza vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388387 | Influenza vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388387 | Influenza vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388388 | Influenza vaccine in nasal dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388388 | Influenza vaccine in nasal dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388388 | Influenza vaccine in nasal dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388389 | Isatuximab only product | Designated preferred name (PT) | NO | |
RxCUI: 2388389 | Isatuximab only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388390 | Isatuximab only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388390 | Isatuximab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388391 | Isavuconazonium only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388391 | Isavuconazonium only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388392 | Japanese encephalitis virus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388392 | Japanese encephalitis virus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388392 | Japanese encephalitis virus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388393 | Product containing only rabies human immune globulin in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2388393 | Product containing only rabies human immune globulin in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2388394 | Rabies vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388394 | Rabies vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388394 | Rabies vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388395 | Product containing only remdesivir (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2388395 | Product containing only remdesivir (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2388396 | Product containing only remdesivir in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2388396 | Product containing only remdesivir in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2388397 | Product containing only rimegepant (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2388397 | Product containing only rimegepant (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2388398 | Product containing only rimegepant in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2388398 | Product containing only rimegepant in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2388399 | Rotavirus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388399 | Rotavirus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388399 | Rotavirus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388400 | Rubella vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388400 | Rubella vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388400 | Rubella vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388401 | Lemborexant only product | Designated preferred name (PT) | NO | |
RxCUI: 2388401 | Lemborexant only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388402 | Lemborexant only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388402 | Lemborexant only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388403 | Live attenuated Human alphaherpesvirus 3 vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388403 | Live attenuated Human alphaherpesvirus 3 vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388403 | Live attenuated Human alphaherpesvirus 3 vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388403 | Live attenuated Human alphaherpesvirus 3 vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388404 | Live attenuated poliovirus serotypes 1 and 3 vaccine in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388404 | Live attenuated poliovirus serotypes 1 and 3 vaccine in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388404 | Live attenuated poliovirus serotypes 1 and 3 vaccine in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388406 | Live attenuated measles and mumps and rubella and varicella-zoster vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388406 | Live attenuated measles and mumps and rubella and varicella-zoster vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388406 | Live attenuated measles and mumps and rubella and varicella-zoster vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388407 | Live attenuated measles, mumps, and rubella vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388407 | Live attenuated measles, mumps, and rubella vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388407 | Live attenuated measles, mumps, and rubella vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388408 | Live attenuated measles and rubella vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388408 | Live attenuated measles and rubella vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388408 | Live attenuated measles and rubella vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388409 | Live attenuated measles vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388409 | Live attenuated measles vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388409 | Live attenuated measles vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388410 | Live attenuated mumps vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388410 | Live attenuated mumps vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388410 | Live attenuated mumps vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388411 | Product containing only sacituzumab govitecan (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2388411 | Product containing only sacituzumab govitecan (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2388412 | Product containing only sacituzumab govitecan in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2388412 | Product containing only sacituzumab govitecan in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2388413 | Typhoid vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388413 | Typhoid vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388413 | Typhoid vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388414 | Typhoid Vi capsular polysaccharide vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388414 | Typhoid Vi capsular polysaccharide vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388414 | Typhoid Vi capsular polysaccharide vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388415 | Typhoid polysaccharide vaccine in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388415 | Typhoid polysaccharide vaccine in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388415 | Typhoid polysaccharide vaccine in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388416 | Product containing only selumetinib (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2388416 | Product containing only selumetinib (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2388417 | Product containing only selumetinib in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2388417 | Product containing only selumetinib in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2388418 | Asenapine only product in transdermal dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388418 | Asenapine only product in transdermal dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388419 | Live attenuated rotavirus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388419 | Live attenuated rotavirus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388419 | Live attenuated rotavirus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388420 | Live attenuated typhoid vaccine in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388420 | Live attenuated typhoid vaccine in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388420 | Live attenuated typhoid vaccine in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388421 | Live attenuated cholera vaccine in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388421 | Live attenuated cholera vaccine in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388421 | Live attenuated cholera vaccine in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388422 | Live attenuated yellow fever vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388422 | Live attenuated yellow fever vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388422 | Live attenuated yellow fever vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388423 | Lomitapide only product | Designated preferred name (PT) | NO | |
RxCUI: 2388423 | Lomitapide only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388424 | Lomitapide only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388424 | Lomitapide only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388425 | Low dose diphtheria vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388425 | Low dose diphtheria vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388425 | Low dose diphtheria vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388426 | Lumateperone only product | Designated preferred name (PT) | NO | |
RxCUI: 2388426 | Lumateperone only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388427 | Lumateperone only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388427 | Lumateperone only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388428 | Product containing only silver sulfadiazine (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2388428 | Product containing only silver sulfadiazine (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2388429 | Product containing only silver sulfadiazine in cutaneous dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2388429 | Product containing only silver sulfadiazine in cutaneous dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2388430 | Autologous cultured chondrocyte only product | Designated preferred name (PT) | NO | |
RxCUI: 2388430 | Autologous cultured chondrocyte only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388431 | Autologous cultured chondrocyte only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388431 | Autologous cultured chondrocyte only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388432 | Avapritinib only product | Designated preferred name (PT) | NO | |
RxCUI: 2388432 | Avapritinib only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388433 | Avapritinib only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388433 | Avapritinib only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388434 | BCG (Bacillus Calmette-Guerin) vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388434 | BCG (Bacillus Calmette-Guerin) vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388434 | BCG (Bacillus Calmette-Guerin) vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388434 | BCG (Bacillus Calmette-Guerin) vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388434 | BCG (Bacillus Calmette-Guerin) vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388435 | BCG (Bacillus Calmette-Guerin) vaccine in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388435 | BCG (Bacillus Calmette-Guerin) vaccine in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388435 | BCG (Bacillus Calmette-Guerin) vaccine in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388435 | BCG (Bacillus Calmette-Guerin) vaccine in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388435 | BCG (Bacillus Calmette-Guerin) vaccine in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388436 | Anthrax vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388436 | Anthrax vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388436 | Anthrax vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388437 | Bempedoic acid and ezetimibe only product | Designated preferred name (PT) | NO | |
RxCUI: 2388437 | Bempedoic acid and ezetimibe only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388438 | Bempedoic acid and ezetimibe only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388438 | Bempedoic acid and ezetimibe only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388439 | Bempedoic acid only product | Designated preferred name (PT) | NO | |
RxCUI: 2388439 | Bempedoic acid only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388440 | Bempedoic acid only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388440 | Bempedoic acid only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388441 | Luspatercept only product | Designated preferred name (PT) | NO | |
RxCUI: 2388441 | Luspatercept only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388442 | Luspatercept only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388442 | Luspatercept only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388443 | Mannitol only product in pulmonary dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388443 | Mannitol only product in pulmonary dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388444 | Measles and mumps and rubella vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388444 | Measles and mumps and rubella vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388444 | Measles and mumps and rubella vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388445 | Measles and rubella vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388445 | Measles and rubella vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388445 | Measles and rubella vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388446 | Measles vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388446 | Measles vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388446 | Measles vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388447 | Meloxicam only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388447 | Meloxicam only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388448 | Mesna only product in pulmonary dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388448 | Mesna only product in pulmonary dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388449 | Diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and poliomyelitis and tetanus | Designated preferred name (PT) | NO | |
RxCUI: 2388449 | Diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and poliomyelitis and tetanus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388449 | Diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and poliomyelitis and tetanus | Full form of descriptor (FN) | NO | |
RxCUI: 2388450 | Diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388450 | Diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388450 | Diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388451 | Diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388451 | Diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388451 | Diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388452 | Diphtheria and Haemophilus influenzae type b and pertussis and tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388452 | Diphtheria and Haemophilus influenzae type b and pertussis and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388452 | Diphtheria and Haemophilus influenzae type b and pertussis and tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388453 | Diphtheria and measles and pertussis and poliomyelitis and tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388453 | Diphtheria and measles and pertussis and poliomyelitis and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388453 | Diphtheria and measles and pertussis and poliomyelitis and tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388454 | Diphtheria and pertussis and poliomyelitis and tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388454 | Diphtheria and pertussis and poliomyelitis and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388454 | Diphtheria and pertussis and poliomyelitis and tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388455 | Diphtheria and pertussis and tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388455 | Diphtheria and pertussis and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388455 | Diphtheria and pertussis and tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388456 | Pertussis vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388456 | Pertussis vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388456 | Pertussis vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388457 | Lyme disease vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388457 | Lyme disease vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388457 | Lyme disease vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388458 | Bromhexine only product | Designated preferred name (PT) | NO | |
RxCUI: 2388458 | Bromhexine only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388459 | Bromhexine only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388459 | Bromhexine only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388460 | Mumps vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388460 | Mumps vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388460 | Mumps vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388461 | Mycophenolic acid only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388461 | Mycophenolic acid only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388462 | Meningococcus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388462 | Meningococcus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388462 | Meningococcus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388463 | Meningitis polysaccharide vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388463 | Meningitis polysaccharide vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388463 | Meningitis polysaccharide vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388464 | Meningitis A and C vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388464 | Meningitis A and C vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388464 | Meningitis A and C vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388465 | Meningococcus A, C, W135 and Y capsular oligosaccharide conjugated vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388465 | Meningococcus A, C, W135 and Y capsular oligosaccharide conjugated vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388465 | Meningococcus A, C, W135 and Y capsular oligosaccharide conjugated vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388466 | Meningococcus A, C, W135 and Y capsular polysaccharide conjugated vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388466 | Meningococcus A, C, W135 and Y capsular polysaccharide conjugated vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388466 | Meningococcus A, C, W135 and Y capsular polysaccharide conjugated vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388467 | Meningitis A, C, W135 and Y vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388467 | Meningitis A, C, W135 and Y vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388467 | Meningitis A, C, W135 and Y vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388468 | Meningococcus serogroup B vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388468 | Meningococcus serogroup B vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388468 | Meningococcus serogroup B vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388469 | Pneumococcal vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388469 | Pneumococcal vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388469 | Pneumococcal vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388470 | Pneumococcal polysaccharide conjugate vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388470 | Pneumococcal polysaccharide conjugate vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388470 | Pneumococcal polysaccharide conjugate vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388471 | Product containing only tazemetostat (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2388471 | Product containing only tazemetostat (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2388472 | Product containing only tazemetostat in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2388472 | Product containing only tazemetostat in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2388473 | Product containing only teprotumumab (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2388473 | Product containing only teprotumumab (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2388474 | Product containing only teprotumumab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2388474 | Product containing only teprotumumab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2388475 | Human tetanus immunoglobulin only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388475 | Human tetanus immunoglobulin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388476 | Cefiderocol only product | Designated preferred name (PT) | NO | |
RxCUI: 2388476 | Cefiderocol only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388477 | Cefiderocol only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388477 | Cefiderocol only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388478 | Cenobamate only product | Designated preferred name (PT) | NO | |
RxCUI: 2388478 | Cenobamate only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388479 | Cenobamate only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388479 | Cenobamate only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388480 | Cetirizine only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388480 | Cetirizine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388481 | Diphtheria and Haemophilus influenzae type b and poliomyelitis and tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388481 | Diphtheria and Haemophilus influenzae type b and poliomyelitis and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388481 | Diphtheria and Haemophilus influenzae type b and poliomyelitis and tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388482 | Diphtheria and hepatitis B and tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388482 | Diphtheria and hepatitis B and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388482 | Diphtheria and hepatitis B and tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388483 | Diphtheria and poliomyelitis and tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388483 | Diphtheria and poliomyelitis and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388483 | Diphtheria and poliomyelitis and tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388484 | Diphtheria and tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388484 | Diphtheria and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388484 | Diphtheria and tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388485 | Adult diphtheria and tetanus toxoids vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388485 | Adult diphtheria and tetanus toxoids vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388485 | Adult diphtheria and tetanus toxoids vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388486 | Poliomyelitis and tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388486 | Poliomyelitis and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388486 | Poliomyelitis and tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388487 | Low dose diphtheria and inactivated poliomyelitis and tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388487 | Low dose diphtheria and inactivated poliomyelitis and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388487 | Low dose diphtheria and inactivated poliomyelitis and tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388488 | Low dose diphtheria and tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388488 | Low dose diphtheria and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388488 | Low dose diphtheria and tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388489 | Meningococcus group C capsular polysaccharide conjugate vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388489 | Meningococcus group C capsular polysaccharide conjugate vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388489 | Meningococcus group C capsular polysaccharide conjugate vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388490 | Meningitis C vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388490 | Meningitis C vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388490 | Meningitis C vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388491 | Tick-borne encephalitis vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388491 | Tick-borne encephalitis vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388491 | Tick-borne encephalitis vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388492 | Product containing only trastuzumab deruxtecan (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2388492 | Product containing only trastuzumab deruxtecan (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2388493 | Product containing only trastuzumab deruxtecan in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2388493 | Product containing only trastuzumab deruxtecan in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2388494 | Product containing only tucatinib (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2388494 | Product containing only tucatinib (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2388495 | Product containing only tucatinib in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2388495 | Product containing only tucatinib in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2388496 | Product containing only ubrogepant (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2388496 | Product containing only ubrogepant (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2388497 | Product containing only ubrogepant in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
RxCUI: 2388497 | Product containing only ubrogepant in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
RxCUI: 2388498 | Tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388498 | Tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388498 | Tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388499 | Tetanus toxoid vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388499 | Tetanus toxoid vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388499 | Tetanus toxoid vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 238850 | povidone-iodine 5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238850 | povidone-iodine 5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238850 | povidone-iodine 5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2388500 | Osilodrostat only product | Designated preferred name (PT) | NO | |
RxCUI: 2388500 | Osilodrostat only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388501 | Osilodrostat only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388501 | Osilodrostat only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388502 | Ozanimod only product | Designated preferred name (PT) | NO | |
RxCUI: 2388502 | Ozanimod only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388503 | Ozanimod only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388503 | Ozanimod only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388504 | Diphtheria and acellular pertussis and Haemophilus influenzae type b and hepatitis B and poliomyelitis and tetanus pediatric vaccine | British preferred term (PTGB) | NO | |
RxCUI: 2388504 | Diphtheria and acellular pertussis and Haemophilus influenzae type b and hepatitis B and poliomyelitis and tetanus pediatric vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388504 | Diphtheria and acellular pertussis and Haemophilus influenzae type b and hepatitis B and poliomyelitis and tetanus pediatric vaccine | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 2388504 | Diphtheria and acellular pertussis and Haemophilus influenzae type b and hepatitis B and poliomyelitis and tetanus pediatric vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388504 | Diphtheria and acellular pertussis and Haemophilus influenzae type b and hepatitis B and poliomyelitis and tetanus pediatric vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388505 | Diphtheria and Haemophilus influenza type b and acellular pertussis and poliomyelitis and tetanus pediatric vaccine | British preferred term (PTGB) | NO | |
RxCUI: 2388505 | Diphtheria and Haemophilus influenza type b and acellular pertussis and poliomyelitis and tetanus pediatric vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388505 | Diphtheria and Haemophilus influenza type b and acellular pertussis and poliomyelitis and tetanus pediatric vaccine | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 2388505 | Diphtheria and Haemophilus influenza type b and acellular pertussis and poliomyelitis and tetanus pediatric vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388505 | Diphtheria and Haemophilus influenza type b and acellular pertussis and poliomyelitis and tetanus pediatric vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388506 | Diphtheria and Haemophilus influenza type b and acellular pertussis and inactivated poliomyelitis and tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388506 | Diphtheria and Haemophilus influenza type b and acellular pertussis and inactivated poliomyelitis and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388506 | Diphtheria and Haemophilus influenza type b and acellular pertussis and inactivated poliomyelitis and tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388507 | Diphtheria and hepatitis B and acellular pertussis and inactivated poliomyelitis and tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388507 | Diphtheria and hepatitis B and acellular pertussis and inactivated poliomyelitis and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388507 | Diphtheria and hepatitis B and acellular pertussis and inactivated poliomyelitis and tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388508 | Diphtheria and acellular pertussis and poliomyelitis and tetanus pediatric vaccine | British preferred term (PTGB) | NO | |
RxCUI: 2388508 | Diphtheria and acellular pertussis and poliomyelitis and tetanus pediatric vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388508 | Diphtheria and acellular pertussis and poliomyelitis and tetanus pediatric vaccine | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 2388508 | Diphtheria and acellular pertussis and poliomyelitis and tetanus pediatric vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388508 | Diphtheria and acellular pertussis and poliomyelitis and tetanus pediatric vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388509 | Diphtheria and acellular pertussis and inactivated poliomyelitis and tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388509 | Diphtheria and acellular pertussis and inactivated poliomyelitis and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388509 | Diphtheria and acellular pertussis and inactivated poliomyelitis and tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 238851 | povidone-iodine 10 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 238851 | povidone-iodine 10 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238851 | povidone-iodine 10 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2388510 | Diphtheria and acellular pertussis and tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388510 | Diphtheria and acellular pertussis and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388510 | Diphtheria and acellular pertussis and tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388511 | Low dose diphtheria and acellular pertussis and inactivated poliomyelitis and tetanus vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388511 | Low dose diphtheria and acellular pertussis and inactivated poliomyelitis and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388511 | Low dose diphtheria and acellular pertussis and inactivated poliomyelitis and tetanus vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388512 | Diphtheria toxoid and acellular pertussis and inactivated poliomyelitis type 1,2, and 3 and tetanus toxoid pediatric vaccine | British preferred term (PTGB) | NO | |
RxCUI: 2388512 | Diphtheria toxoid and acellular pertussis and inactivated poliomyelitis type 1,2, and 3 and tetanus toxoid pediatric vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388512 | Diphtheria toxoid and acellular pertussis and inactivated poliomyelitis type 1,2, and 3 and tetanus toxoid pediatric vaccine | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 2388512 | Diphtheria toxoid and acellular pertussis and inactivated poliomyelitis type 1,2, and 3 and tetanus toxoid pediatric vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388512 | Diphtheria toxoid and acellular pertussis and inactivated poliomyelitis type 1,2, and 3 and tetanus toxoid pediatric vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388513 | Diphtheria and hepatitis B and inactivated poliomyelitis and acellular pertussis vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388513 | Diphtheria and hepatitis B and inactivated poliomyelitis and acellular pertussis vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388513 | Diphtheria and hepatitis B and inactivated poliomyelitis and acellular pertussis vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388514 | Diphtheria toxoid and Haemophilus influenzae type b conjugate and acellular pertussis and tetanus toxoid pediatric vaccine | British preferred term (PTGB) | NO | |
RxCUI: 2388514 | Diphtheria toxoid and Haemophilus influenzae type b conjugate and acellular pertussis and tetanus toxoid pediatric vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388514 | Diphtheria toxoid and Haemophilus influenzae type b conjugate and acellular pertussis and tetanus toxoid pediatric vaccine | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 2388514 | Diphtheria toxoid and Haemophilus influenzae type b conjugate and acellular pertussis and tetanus toxoid pediatric vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388514 | Diphtheria toxoid and Haemophilus influenzae type b conjugate and acellular pertussis and tetanus toxoid pediatric vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388515 | Acellular pertussis vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388515 | Acellular pertussis vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388515 | Acellular pertussis vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388516 | Diphtheria toxoid, Haemophilus influenzae type b conjugate, hepatitis B surface antigen, acellular pertussis and tetanus toxoid pediatric vaccine | British preferred term (PTGB) | NO | |
RxCUI: 2388516 | Diphtheria toxoid, Haemophilus influenzae type b conjugate, hepatitis B surface antigen, acellular pertussis and tetanus toxoid pediatric vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388516 | Diphtheria toxoid, Haemophilus influenzae type b conjugate, hepatitis B surface antigen, acellular pertussis and tetanus toxoid pediatric vaccine | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 2388516 | Diphtheria toxoid, Haemophilus influenzae type b conjugate, hepatitis B surface antigen, acellular pertussis and tetanus toxoid pediatric vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388516 | Diphtheria toxoid, Haemophilus influenzae type b conjugate, hepatitis B surface antigen, acellular pertussis and tetanus toxoid pediatric vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388517 | Adenovirus antigen only vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2388517 | Adenovirus antigen only vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2388518 | Adult diphtheria toxoid and acellular pertussis and tetanus toxoid vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388518 | Adult diphtheria toxoid and acellular pertussis and tetanus toxoid vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388518 | Adult diphtheria toxoid and acellular pertussis and tetanus toxoid vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388519 | Diphtheria vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388519 | Diphtheria vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388519 | Diphtheria vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388520 | Q fever vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388520 | Q fever vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388520 | Q fever vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388521 | Crizanlizumab only product | Designated preferred name (PT) | NO | |
RxCUI: 2388521 | Crizanlizumab only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388522 | Crizanlizumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388522 | Crizanlizumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388523 | Cysteine only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388523 | Cysteine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388524 | Cytomegalovirus immunoglobulin only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388524 | Cytomegalovirus immunoglobulin only product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388524 | Cytomegalovirus immunoglobulin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388525 | Pemigatinib only product | Designated preferred name (PT) | NO | |
RxCUI: 2388525 | Pemigatinib only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388526 | Pemigatinib only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388526 | Pemigatinib only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388527 | Pirfenidone only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388527 | Pirfenidone only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388528 | Afamelanotide only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388528 | Afamelanotide only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388529 | Amisulpride only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388529 | Amisulpride only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388530 | Amoxicillin and omeprazole and rifabutin only product | Designated preferred name (PT) | NO | |
RxCUI: 2388530 | Amoxicillin and omeprazole and rifabutin only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388531 | Amoxicillin and omeprazole and rifabutin only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388531 | Amoxicillin and omeprazole and rifabutin only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388532 | Dapagliflozin and metformin and saxagliptin only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388532 | Dapagliflozin and metformin and saxagliptin only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388533 | Dengue vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388533 | Dengue vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2388533 | Dengue vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2388534 | Ebolavirus antigen only vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2388534 | Ebolavirus antigen only vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2388535 | Eliglustat only product in oral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388535 | Eliglustat only product in oral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388536 | Enfortumab vedotin only product | Designated preferred name (PT) | NO | |
RxCUI: 2388536 | Enfortumab vedotin only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388537 | Enfortumab vedotin only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388537 | Enfortumab vedotin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388538 | Eptinezumab only product | Designated preferred name (PT) | NO | |
RxCUI: 2388538 | Eptinezumab only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388539 | Eptinezumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388539 | Eptinezumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388540 | Equine diphtheria antitoxin only product | Designated preferred name (PT) | NO | |
RxCUI: 2388540 | Equine diphtheria antitoxin only product | Full form of descriptor (FN) | NO | |
RxCUI: 2388541 | Equine diphtheria antitoxin only product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388541 | Equine diphtheria antitoxin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388542 | Antigen of Haemophilus influenzae type b Eagan strain capsular polysaccharide polyribosylribitol phosphate conjugated to Corynebacterium diphtheriae toxoid protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388542 | Antigen of Haemophilus influenzae type b Eagan strain capsular polysaccharide polyribosylribitol phosphate conjugated to Corynebacterium diphtheriae toxoid protein | Full form of descriptor (FN) | NO | |
RxCUI: 2388542 | Antigen of Haemophilus influenzae type b Eagan strain capsular polysaccharide polyribosylribitol phosphate conjugated to Corynebacterium diphtheriae toxoid protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388542 | Antigen of Haemophilus influenzae type b Eagan strain capsular polysaccharide polyribosylribitol phosphate conjugated to Corynebacterium diphtheriae toxoid protein | Designated preferred name (PT) | NO | |
RxCUI: 2388543 | Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388543 | Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein | Full form of descriptor (FN) | NO | |
RxCUI: 2388543 | Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388543 | Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein | Designated preferred name (PT) | NO | |
RxCUI: 2388544 | Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Corynebacterium diphtheriae cross-reacting material 197 protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388544 | Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Corynebacterium diphtheriae cross-reacting material 197 protein | Full form of descriptor (FN) | NO | |
RxCUI: 2388544 | Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Corynebacterium diphtheriae cross-reacting material 197 protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388544 | Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Corynebacterium diphtheriae cross-reacting material 197 protein | Designated preferred name (PT) | NO | |
RxCUI: 2388545 | Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Corynebacterium diphtheriae toxoid protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388545 | Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Corynebacterium diphtheriae toxoid protein | Full form of descriptor (FN) | NO | |
RxCUI: 2388545 | Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Corynebacterium diphtheriae toxoid protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388545 | Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Corynebacterium diphtheriae toxoid protein | Designated preferred name (PT) | NO | |
RxCUI: 2388546 | Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Neisseria meningitidis serogroup B outer membrane protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388546 | Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Neisseria meningitidis serogroup B outer membrane protein | Full form of descriptor (FN) | NO | |
RxCUI: 2388546 | Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Neisseria meningitidis serogroup B outer membrane protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388546 | Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Neisseria meningitidis serogroup B outer membrane protein | Designated preferred name (PT) | NO | |
RxCUI: 238856 | boric acid 25 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2388581 | carbetapentane citrate 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2388582 | potassium guaiacolsulfonate 45 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2388586 | Daffodil pollen | Designated preferred name (PT) | NO | |
RxCUI: 2388586 | Daffodil pollen | Full form of descriptor (FN) | NO | |
RxCUI: 2388588 | Snakeweed pollen | Designated preferred name (PT) | NO | |
RxCUI: 2388588 | Snakeweed pollen | Full form of descriptor (FN) | NO | |
RxCUI: 2388589 | axicabtagene ciloleucel 2940000 CELLS/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 238859 | chloroxylenol 20 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2388591 | axicabtagene ciloleucel 2940000 CELLS/ML [Yescarta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2388593 | axicabtagene ciloleucel 2940000 CELLS/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2388594 | axicabtagene ciloleucel 2940000 CELLS/ML Injection [Yescarta] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2388594 | axicabtagene ciloleucel 2940000 CELLS/ML Injection [Yescarta] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388595 | Colecalciferol 625 microgram/mL oral solution | Designated preferred name (PT) | NO | |
RxCUI: 2388595 | Colecalciferol 625 microgram/mL oral solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388595 | Colecalciferol 625 microgram/mL oral solution | Full form of descriptor (FN) | NO | |
RxCUI: 2388601 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML [S-T Forte 2] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2388601 | chlorpheniramine maleate 0.4 MG/ML / hydrocodone bitartrate 0.5 MG/ML [S-T Forte 2] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 2388606 | hydroiodic acid 0.334 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2388608 | Adenovirus antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2388608 | Adenovirus antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2388609 | Product containing precisely autologous cultured chondrocyte 30 million unit/1 milliliter conventional release intraarticular implant (clinical drug) | Designated preferred name (PT) | NO | |
RxCUI: 2388609 | Product containing precisely autologous cultured chondrocyte 30 million unit/1 milliliter conventional release intraarticular implant (clinical drug) | Full form of descriptor (FN) | NO | |
RxCUI: 2388611 | Autologous cultured chondrocyte-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2388611 | Autologous cultured chondrocyte-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2388612 | Autologous cultured chondrocyte-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
RxCUI: 2388612 | Autologous cultured chondrocyte-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
RxCUI: 2388613 | phenindamine tartrate 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2388614 | Bacillus anthracis antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2388614 | Bacillus anthracis antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2388616 | Live attenuated Mycobacterium bovis antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2388616 | Live attenuated Mycobacterium bovis antigen-containing vaccine product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2388616 | Live attenuated Mycobacterium bovis antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2388617 | Bacteria and virus antigens-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2388617 | Bacteria and virus antigens-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2388618 | Bacteria antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2388618 | Bacteria antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2388619 | Amphenicol | Designated preferred name (PT) | NO | |
RxCUI: 2388619 | Amphenicol | Full form of descriptor (FN) | NO | |
RxCUI: 2388619 | Amphenicol | Designated preferred name (PT) | NO | |
RxCUI: 2388619 | Amphenicol | Full form of descriptor (FN) | NO | |
RxCUI: 2388621 | Benzamide structure-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2388621 | Benzamide structure-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2388621 | Benzamide structure-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2388621 | Benzamide structure-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2388622 | fludrocortisone acetate 0.1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2388624 | fludrocortisone acetate 0.1 MG [Florinef] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 238889 | lidocaine / povidone-iodine Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 238909 | benzocaine 5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238909 | benzocaine 5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238909 | benzocaine 5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238910 | benzocaine 20 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238910 | benzocaine 20 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238910 | benzocaine 20 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238910 | benzocaine 20 % Oral Gel | Designated preferred name (PT) | YES | |
RxCUI: 238910 | benzocaine 20 % Oral Gel | Full form of descriptor (FN) | YES | |
RxCUI: 238913 | dichlorodifluoromethane 8.5 % / trichlorotrifluoroethane 1.5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 238913 | dichlorodifluoromethane 8.5 % / trichlorotrifluoroethane 1.5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238913 | dichlorodifluoromethane 8.5 % / trichlorotrifluoroethane 1.5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238920 | betamethasone 0.05 % Topical Cream | Designated preferred name (PT) | YES | |
RxCUI: 238920 | betamethasone 0.05 % Topical Cream | Designated preferred name (PT) | YES | |
RxCUI: 238920 | betamethasone 0.05 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 238920 | betamethasone 0.05 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238920 | betamethasone 0.05 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 238920 | betamethasone 0.05 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 238920 | betamethasone 0.05 % Topical Cream | Full form of descriptor (FN) | YES | |
RxCUI: 238920 | betamethasone 0.05 % Topical Cream | Full form of descriptor (FN) | YES | |
RxCUI: 2389302 | triamcinolone acetonide 21-dipotassium phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 2389303 | laneth-75 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2389311 | influenza A virus A/Hawaii/66/2019 (H1N1) antigen / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 2389312 | Flumist Quadrivalent 2020-2021 Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2389313 | FluMist Quadrivalent, 2020-2021 Formula Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2389313 | FluMist Quadrivalent, 2020-2021 Formula Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389313 | FluMist Quadrivalent, 2020-2021 Formula Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 2389314 | Flumist Quadrivalent 2020-2021 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 2389315 | Flumist Quadrivalent 2020-2021 Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 2389316 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [Flumist Quadrivalent 2020-2021] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 2389317 | influenza virus vaccine, 2020-2021 Quadrivalent Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2389317 | influenza virus vaccine, 2020-2021 Quadrivalent Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2389317 | influenza virus vaccine, 2020-2021 Quadrivalent Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389318 | influenza A virus A/Hawaii/66/2019 (H1N1) antigen 158000000 UNT/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML / influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML [Flumist Quadrivalent 2020-2021] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 2389328 | Aldehyde dehydrogenase inhibitor | Designated preferred name (PT) | NO | |
RxCUI: 2389328 | Aldehyde dehydrogenase inhibitor | Designated preferred name (PT) | NO | |
RxCUI: 2389328 | Aldehyde dehydrogenase inhibitor | Full form of descriptor (FN) | NO | |
RxCUI: 2389328 | Aldehyde dehydrogenase inhibitor | Full form of descriptor (FN) | NO | |
RxCUI: 2389330 | Haemoglobin S polymerization inhibitor | British preferred term (PTGB) | NO | |
RxCUI: 2389330 | Haemoglobin S polymerization inhibitor | Designated preferred name (PT) | NO | |
RxCUI: 2389330 | Haemoglobin S polymerization inhibitor | Full form of descriptor (FN) | NO | |
RxCUI: 2389332 | Renin-angiotensin system inhibitor | Designated preferred name (PT) | NO | |
RxCUI: 2389332 | Renin-angiotensin system inhibitor | Full form of descriptor (FN) | NO | |
RxCUI: 2389333 | Product containing serpin protease inhibitor (product) | Full form of descriptor (FN) | NO | |
RxCUI: 2389333 | Product containing serpin protease inhibitor (product) | Designated preferred name (PT) | NO | |
RxCUI: 2389334 | Steroid 11-beta-hydroxylase inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389334 | Steroid 11-beta-hydroxylase inhibitor | Designated preferred name (PT) | NO | |
RxCUI: 2389334 | Steroid 11-beta-hydroxylase inhibitor | Full form of descriptor (FN) | NO | |
RxCUI: 2389335 | Colecalciferol 175 microgram oral capsule | Designated preferred name (PT) | NO | |
RxCUI: 2389335 | Colecalciferol 175 microgram oral capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389335 | Colecalciferol 175 microgram oral capsule | Full form of descriptor (FN) | NO | |
RxCUI: 2389336 | Glucosamine (as glucosamine sulfate potassium chloride) 400 mg oral capsule | Designated preferred name (PT) | NO | |
RxCUI: 2389336 | Glucosamine (as glucosamine sulfate potassium chloride) 400 mg oral capsule | Full form of descriptor (FN) | NO | |
RxCUI: 2389344 | Hepatitis A virus antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389344 | Hepatitis A virus antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389348 | Influenza virus antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389348 | Influenza virus antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389350 | Fir pollen | Designated preferred name (PT) | NO | |
RxCUI: 2389350 | Fir pollen | Full form of descriptor (FN) | NO | |
RxCUI: 2389351 | Firebrush pollen | Designated preferred name (PT) | NO | |
RxCUI: 2389351 | Firebrush pollen | Full form of descriptor (FN) | NO | |
RxCUI: 2389352 | Noble fir pollen | Designated preferred name (PT) | NO | |
RxCUI: 2389352 | Noble fir pollen | Full form of descriptor (FN) | NO | |
RxCUI: 238936 | erythromycin 2 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 238936 | erythromycin 2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 238936 | erythromycin 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389632 | hydrogenated polydecene (1500 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2389635 | sodium S-(2-hydroxy-3-(3-(trihydroxysilyl)propoxy)propyl) sulfurothioate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2389636 | ethylene glycol allyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2389637 | ceramide 4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 2389641 | Artemisia pollen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389641 | Artemisia pollen | Designated preferred name (PT) | NO | |
RxCUI: 2389641 | Artemisia pollen | Full form of descriptor (FN) | NO | |
RxCUI: 2389642 | Pinus ponderosa pollen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389642 | Pinus ponderosa pollen | Full form of descriptor (FN) | NO | |
RxCUI: 2389642 | Pinus ponderosa pollen | Designated preferred name (PT) | NO | |
RxCUI: 2389642 | Pinus ponderosa pollen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389643 | Zotarolimus 1.6 microgram/mm2 drug eluting stent | Designated preferred name (PT) | NO | |
RxCUI: 2389643 | Zotarolimus 1.6 microgram/mm2 drug eluting stent | Full form of descriptor (FN) | NO | |
RxCUI: 2389644 | Everolimus 100 microgram/cm2 drug eluting stent | Designated preferred name (PT) | NO | |
RxCUI: 2389644 | Everolimus 100 microgram/cm2 drug eluting stent | Full form of descriptor (FN) | NO | |
RxCUI: 2389645 | Sirolimus 140 microgram/cm2 drug eluting stent | Designated preferred name (PT) | NO | |
RxCUI: 2389645 | Sirolimus 140 microgram/cm2 drug eluting stent | Full form of descriptor (FN) | NO | |
RxCUI: 2389646 | Paclitaxel 1 microgram/mm2 drug eluting stent | Designated preferred name (PT) | NO | |
RxCUI: 2389646 | Paclitaxel 1 microgram/mm2 drug eluting stent | Full form of descriptor (FN) | NO | |
RxCUI: 2389647 | Fibric acid and/or fibric acid derivative-containing product | Designated preferred name (PT) | NO | |
RxCUI: 2389647 | Fibric acid and/or fibric acid derivative-containing product | Full form of descriptor (FN) | NO | |
RxCUI: 2389661 | ethanol 63 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2389661 | ethanol 63 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2389661 | ethanol 63 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389666 | Vaccine product containing Vaccinia virus antigen (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2389666 | Vaccine product containing Vaccinia virus antigen (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2389670 | Cestode antigen | Designated preferred name (PT) | NO | |
RxCUI: 2389670 | Cestode antigen | Full form of descriptor (FN) | NO | |
RxCUI: 2389671 | Nicotine bitartrate dihydrate | Designated preferred name (PT) | NO | |
RxCUI: 2389671 | Nicotine bitartrate dihydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2389673 | Antigen of Filaria | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389673 | Antigen of Filaria | Full form of descriptor (FN) | NO | |
RxCUI: 2389673 | Antigen of Filaria | Designated preferred name (PT) | NO | |
RxCUI: 2389673 | Antigen of Filaria | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389675 | Fluoroquinolone | Designated preferred name (PT) | NO | |
RxCUI: 2389675 | Fluoroquinolone | Full form of descriptor (FN) | NO | |
RxCUI: 2389681 | Loop diuretic agent | Designated preferred name (PT) | NO | |
RxCUI: 2389681 | Loop diuretic agent | Full form of descriptor (FN) | NO | |
RxCUI: 2389682 | ethanol 0.94 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 2389683 | ethanol 94 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2389683 | ethanol 94 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 2389683 | ethanol 94 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389684 | Francisella tularensis antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389684 | Francisella tularensis antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389686 | Vaccine product containing Vibrio cholerae antigen (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2389686 | Vaccine product containing Vibrio cholerae antigen (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2389687 | Vaccine product containing virus antigen (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2389687 | Vaccine product containing virus antigen (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2389688 | Vaccine product containing Yellow fever virus antigen (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2389688 | Vaccine product containing Yellow fever virus antigen (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2389689 | Hepatitis B virus antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389689 | Hepatitis B virus antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389690 | Varicella-zoster virus antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389690 | Varicella-zoster virus antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389690 | Varicella-zoster virus antigen-containing vaccine product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389691 | Human papillomavirus antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389691 | Human papillomavirus antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389692 | Human poliovirus antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389692 | Human poliovirus antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389693 | Vaccine product containing Yersinia pestis antigen (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2389693 | Vaccine product containing Yersinia pestis antigen (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2389694 | Japanese encephalitis virus antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389694 | Japanese encephalitis virus antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389695 | Rabies lyssavirus antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389695 | Rabies lyssavirus antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389696 | Rickettsia antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389696 | Rickettsia antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389697 | Rotavirus antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389697 | Rotavirus antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389698 | Rubella virus antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389698 | Rubella virus antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389699 | Vaccine product containing Junin virus antigen (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2389699 | Vaccine product containing Junin virus antigen (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 23897 | Multiple acyl coenzyme A dehydrogenase | Designated preferred name (PT) | NO | |
RxCUI: 23897 | Multiple acyl coenzyme A dehydrogenase | Full form of descriptor (FN) | NO | |
RxCUI: 23897 | Multiple acyl coenzyme A dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 23897 | Multiple acyl coenzyme A dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 23897 | Multiple acyl coenzyme A dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389700 | Leptospira antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389700 | Leptospira antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389701 | Live attenuated Argentinian hemorrhagic fever vaccine | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 2389701 | Live attenuated Argentinian hemorrhagic fever vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389701 | Live attenuated Argentinian hemorrhagic fever vaccine | Designated preferred name (PT) | NO | |
RxCUI: 2389701 | Live attenuated Argentinian hemorrhagic fever vaccine | Full form of descriptor (FN) | NO | |
RxCUI: 2389702 | Salmonella enterica subspecies enterica serovar Typhi antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389702 | Salmonella enterica subspecies enterica serovar Typhi antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389703 | Vaccine product containing Measles morbillivirus antigen (medicinal product) | Designated preferred name (PT) | NO | |
RxCUI: 2389703 | Vaccine product containing Measles morbillivirus antigen (medicinal product) | Full form of descriptor (FN) | NO | |
RxCUI: 2389704 | Bordetella pertussis antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389704 | Bordetella pertussis antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389705 | Borrelia burgdorferi antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389705 | Borrelia burgdorferi antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389706 | Mumps orthorubulavirus antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389706 | Mumps orthorubulavirus antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389707 | Neisseria meningitidis antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389707 | Neisseria meningitidis antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389708 | Streptococcus pneumoniae antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389708 | Streptococcus pneumoniae antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389709 | Tick-borne encephalitis virus antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389709 | Tick-borne encephalitis virus antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389710 | Clostridium tetani antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389710 | Clostridium tetani antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389712 | Corynebacterium diphtheriae antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389712 | Corynebacterium diphtheriae antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389714 | Coxiella burnetii antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389714 | Coxiella burnetii antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389715 | Dengue virus antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389715 | Dengue virus antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389716 | Ebolavirus antigen-containing vaccine product | Designated preferred name (PT) | NO | |
RxCUI: 2389716 | Ebolavirus antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
RxCUI: 2389720 | Deer fly salivary protein | Designated preferred name (PT) | NO | |
RxCUI: 2389720 | Deer fly salivary protein | Full form of descriptor (FN) | NO | |
RxCUI: 2389721 | Insect debris | Designated preferred name (PT) | NO | |
RxCUI: 2389721 | Insect debris | Full form of descriptor (FN) | NO | |
RxCUI: 2389722 | Retinyl ester | Designated preferred name (PT) | NO | |
RxCUI: 2389722 | Retinyl ester | Full form of descriptor (FN) | NO | |
RxCUI: 2389724 | Medicinal product acting as passive immunity stimulant (product) | Full form of descriptor (FN) | NO | |
RxCUI: 2389724 | Medicinal product acting as passive immunity stimulant (product) | Designated preferred name (PT) | NO | |
RxCUI: 2389730 | Paclitaxel coated angioplasty balloon catheter | Designated preferred name (PT) | NO | |
RxCUI: 2389730 | Paclitaxel coated angioplasty balloon catheter | Full form of descriptor (FN) | NO | |
RxCUI: 2389731 | Antigen of Human immunodeficiency virus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389731 | Antigen of Human immunodeficiency virus | Full form of descriptor (FN) | NO | |
RxCUI: 2389731 | Antigen of Human immunodeficiency virus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389731 | Antigen of Human immunodeficiency virus | Designated preferred name (PT) | NO | |
RxCUI: 2389732 | Antigen of Human immunodeficiency virus 2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389732 | Antigen of Human immunodeficiency virus 2 | Full form of descriptor (FN) | NO | |
RxCUI: 2389732 | Antigen of Human immunodeficiency virus 2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389732 | Antigen of Human immunodeficiency virus 2 | Designated preferred name (PT) | NO | |
RxCUI: 2389733 | Antigen of Human papillomavirus 9 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389733 | Antigen of Human papillomavirus 9 | Full form of descriptor (FN) | NO | |
RxCUI: 2389733 | Antigen of Human papillomavirus 9 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389733 | Antigen of Human papillomavirus 9 | Designated preferred name (PT) | NO | |
RxCUI: 2389759 | Nalmefene hydrochloride dihydrate | Designated preferred name (PT) | NO | |
RxCUI: 2389759 | Nalmefene hydrochloride dihydrate | Full form of descriptor (FN) | NO | |
RxCUI: 2389840 | viltolarsen | Full form of descriptor (FN) | YES | |
RxCUI: 2389840 | viltolarsen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 2389840 | viltolarsen | Designated preferred name (PT) | YES | |
RxCUI: 2389840 | viltolarsen | Full form of descriptor (FN) | YES | |
RxCUI: 2389840 | viltolarsen | Designated preferred name (PT) | YES | |
RxCUI: 2389841 | viltolarsen 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 2389842 | viltolarsen Injectable Product | Full form of descriptor (FN) | YES | |
RxCUI: 2389842 | viltolarsen Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 2389842 | viltolarsen Injectable Product | Designated preferred name (PT) | YES | |
RxCUI: 2389843 | viltolarsen Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 2389844 | viltolarsen 250 MG in 5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 2389844 | viltolarsen 250 MG in 5 ML Injection | Full form of descriptor (FN) | YES | |
RxCUI: 2389844 | viltolarsen 250 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2389844 | viltolarsen 250 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2389844 | viltolarsen 250 MG in 5 ML Injection | Designated preferred name (PT) | YES | |
RxCUI: 2389845 | Viltepso | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 2389846 | viltolarsen 50 MG/ML [Viltepso] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 2389847 | viltolarsen Injection [Viltepso] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 2389848 | Viltepso Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 2389849 | VILTEPSO 250 MG in 5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2389849 | VILTEPSO 250 MG in 5 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 2389849 | VILTEPSO 250 MG in 5 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 2389849 | VILTEPSO 250 MG in 5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 2389850 | viltolarsen 50 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 2389851 | viltolarsen 50 MG/ML Injection [Viltepso] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 2389851 | viltolarsen 50 MG/ML Injection [Viltepso] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 238996 | phenylephrine HCl 0.125 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 238996 | phenylephrine HCl 0.125 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 238996 | phenylephrine HCl 0.125 % Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |